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The fi rst issue of Drugnet Ireland to appear in the new electronic format (Issue 25) was published in 
April. Anyone wishing to subscribe just needs to fi ll in and submit an online form. All future issues 
will then be delivered directly to your desktop. The electronic newsletter is in the form of a micro 
website. The front page is included in an email and from here you can read the contents by simply 
clicking on the title of the article. 
This is an important development for our newsletter. Interest continues to grow and we are aware 
of the need to make the contents more widely available with each issue. However, costs are also 
increasing. Publishing in electronic format is cost effective and will help us to maintain the level 
and frequency of output. 
Publishing this way also means that fewer resources are consumed than in traditional publishing. 
It is therefore a more sustainable approach and, in this spirit, we would ask you to consider opting 
for the electronic version of Drugnet Ireland, rather than the print copy. You can choose this option 
on the online form. We are well aware of the convenience of having a physical, transportable copy, 
but you will fi nd that the electronic newsletter is attractive and simple to use, and the content is 
easy to disseminate should you want to pass it on to a colleague. It will also make archiving easier 
and will enable us to add value to the content by linking to other online resources such as the 
National Documentation Centre.
Thank you for your support and interest over the past 25 issues of Drugnet Ireland. If you have 
any comments on the electronic version or suggestions for improvement please send them to 
drugnet@hrb.ie.
The current issue is available at http://newsweaver.ie/drugnet. Please go to the Subscribe/
Unsubscribe link in the left margin and fi ll in the subscription form. 
On 13 May the Taoiseach appointed Deputy 
John Curran, Fianna Fáil TD for Dublin Mid 
West, as Minister of State at the Department of 
Community, Rural and Gaeltacht Affairs with 
special responsibility for drugs strategy and 
community affairs. Deputy Curran is a member 
of the Dáil Committee on Public Accounts and 
the Joint Committee on Child Protection. He has 
been a member of the National Economic and 
Social Forum (NESF) since 2004. 
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On 14 May 2008, the Health Research Board 
published trends in treated problem drug use 
based on data reported to the National Drug 
Treatment Reporting System (NDTRS) and to 
the Central Treatment List (CTL).1 It is important 
to note that the reporting system collects 
data on episodes of treatment, rather than 
the number of individual people treated each 
year. This means that individuals may appear 
more than once if they attend more than one 
treatment service in a year, and may reappear in 
subsequent years.
The main fi ndings and their implications are:
There were 68,754 cases treated between  ■
2001 and 2006, of which 31,620 entered 
treatment during the six-year period. Of 
these cases, 29,373 (93%) lived in Ireland 
at an identifi ed address, 2,203 (7%) lived 
in Ireland at an unidentifi ed address and 44 
(0.1%) did not live in Ireland.
In Ireland, treatment for problem drug use  ■
is provided in outpatient, inpatient, low-
threshold and general practice settings. Of 
the 68,754 cases treated between 2001 
and 2006, the majority (68%) attended 
outpatient services. 
The number of individuals in methadone  ■
treatment from the preceding calendar year 
and carried forward on 1 January each year 
increased by 46%, from 4,963 in 2001 to 
7,269 in 2006. 
Just over 2,300 methadone treatment places  ■
have been created since the beginning 
of the current National Drugs Strategy 
(2001–2008) and the number of outpatient 
services has increased by 25%.
Of the 5,191 cases entering treatment for  ■
problem drug use in 2006, 51% received 
counselling as an initial intervention, 39% 
received methadone substitution, 17% 
received a brief intervention and 14% 
attended medication-free therapy. Thirty-six 
per cent of cases received more than one 
initial treatment intervention. 
The prevalence (all cases) of treated problem  ■
drug use among 15–64-year-olds living 
in Ireland, expressed per 100,000 of the 
population, increased by 15%, from 372 in 
2001 to 426 in 2006. 
The incidence (new cases) of treated  ■
problem drug use among 15–64-year-olds 
living in Ireland was marginally lower in 
2006 (74.8 new cases per 100,000) than in 
2001 (75.7 new cases). 
The relatively stable incidence observed  ■
during the period masks separate trends in 
the former health board areas. The number 
of new cases increased by 100% in the 
Western, by 57% in the Midland, by 37% 
in the North Eastern and by 33% in the 
Mid-Western health board areas between 
2001 and 2006. The number of new cases 
increased by 89% in the South Eastern 
Health Board area between 2001 and 2005 
and then stabilised. 
An opiate (mainly heroin) was the most  ■
common main problem drug reported by 
new cases who lived in Dublin. There was a 
31% decrease in the number of new opiate 
cases who lived in Dublin, from 675 in 2001 
to 468 in 2006, indicating that the heroin 
epidemic in this area has abated. In contrast, 
there was a 96% increase in the number of 
new opiate cases who lived outside Dublin, 
from 226 in 2001 to 442 in 2006. 
The main problem drugs reported by new  ■
cases were cannabis (41%), opiates (39%) 
and cocaine (9%). The number of new cases 
who reported cocaine as their main problem 
drug increased noticeably, from 43 in 2001 
to 342 in 2006. The number of new cases 
reporting cannabis as their main problem 
drug increased marginally. 
The vast majority (72%) of new cases  ■
treated between 2001 and 2006 reported 
problem use of more than one substance 
(polysubstance use). 
In total, 2,473 new injector cases entered  ■
treatment between 2001 and 2006. Over 
half of these were still injecting on entry 
to treatment, and 47% reported sharing 
injecting equipment. The proportion 
of injector cases who reported sharing 
equipment decreased from 51% in 2001 to 
44% in 2006, which indicates the positive 
effect of proactive outreach work.
In general, problem drug users are young  ■
and male, have low levels of education and 
are unlikely to be employed, indicating the 
importance of personal development and 
educational and employment opportunities 
as part of the drug treatment and 
reintegration process. 
Though small, the proportion of cases who  ■
reported being homeless and the proportion 
not born in Ireland increased steadily during 
the reporting period. The increase in the 
proportion of other nationalities seeking 
treatment may have implications for service 
provision as drug treatment interventions 
rely heavily on verbal communication.
(Jean Long)
1. Reynolds S, Fanagan S, Bellerose D and Long 
J (2008) Trends in treated problem drug use 
in Ireland, 2001 to 2006. HRB Trends Series 2. 
Dublin: Health Research Board.
contents
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3On 29 April 2008, the Department of Health and Children 
published the third SLAN survey of lifestyle, attitudes and 
nutrition in Ireland. The then Minister for Health Promotion 
and Food Safety Pat The Cope Gallagher TD launched the 
fi ndings for Ireland.1 
The survey involved 10,364 face-to-face interviews with 
adults resident in Ireland, which represented a 62% response 
rate. The sample was drawn from the GeoDirectory using 
a multi-stage probability procedure, and was stratifi ed by 
townland, urban–rural location, age and social class. 
Respondents were asked a number of questions about their 
alcohol and drug use. The responses were weighted for age, 
gender, marital status, country of birth and ethnicity. 
Respondents who had not consumed alcohol in the 12 
months prior to the survey included:
almost one in fi ve of those surveyed ■
23% of women and 15% of men surveyed ■
two in fi ve of those aged over 65 years ■
almost one-quarter of respondents classifi ed as social  ■
class 5 or 6.2 
Respondents who had consumed alcohol four or more times 
per week in the 12 months prior to the survey included:
8% of those surveyed ■
11% of men and 5% of women surveyed ■
one in ten of those aged between 45 and 64 years ■
one in ten of those classifi ed as social class 1 or 2. ■ 2
Respondents who had consumed six or more standard drinks 
on one or more occasions per week in the 12 months prior 
to the survey included:
28% of those surveyed  ■
38% of men and 17% of women surveyed ■
two in fi ve of those aged between 18 and 29 years ■
just over one-third of those classifi ed as social class  ■
5 or 6. 
The proportion reporting that they drank six or more 
standard drinks on one or more occasion per week in the 
year prior to the survey fell from 45% in 2002 to 28% 
in 2007. This decrease was observed across gender, age 
and social class. Some reduction in the proportion of 
the population that engaged in binge drinking could be 
expected as a result of the increase in excise on spirits, 
but this decrease is larger than expected. In addition, the 
authors note that this fi nding must be interpreted with 
caution because of the change in sample selection and data-
collection methods in 2007 compared to those in 2002 and 
1998, as shown in Table 1.
Sixty-seven per cent of the respondents who drank alcohol 
were car drivers, of whom 12% reported that they had 
driven in the year prior to the survey after consuming two or 
more standard drinks. More men (17%) than women (5%) 
reported this practice. Respondents classifi ed in social class 
5 or 6 were more likely to report this practice than those in 
other social classes, 15% compared to 12%. The percentage 
of drivers who reported this practice decreased from 16% in 
2002 to 12% in 2007. This decrease is to be expected since 
random breath testing for drivers was introduced in June 
2006. In addition, the different data-collection method used 
may account for a proportion of the change (Table 1). 
Respondents were asked about their use of illegal drugs 
in the last year (Table 2). Six per cent reported that they 
had used an illegal drug in the year prior to the survey; 
the reported use of such drugs was higher for men (9%) 
than for women (4%). As expected, cannabis was the most 
commonly used drug. The percentage of those who used 
cocaine in the last year was surprisingly low at 1%. 
Alcohol and drug data from third SLAN 
survey
Table 1 Summary of SLAN methods, 1998, 2002 and 2007
SLAN 1998 SLAN 2002 SLAN 2007
Population Adults aged 18+ Adults aged 18+ Adults aged 18+
Sampling frame Electoral register Electoral register GeoDirectory
Sample Multi-stage sample, drawn 
by electoral division
Multi-stage sample, drawn 
by electoral division
Multi-stage probability 
sample
Stratifi cation Percentage distribution 
across each of 26 counties, 
locality and gender
Percentage distribution 
across each of 26 counties, 
locality and gender
Percentage distribution 
across townlands, age 
groups, social classes and 
urban–rural location
Methods Self-completion 
questionnaire and self-
completion of Food 
Frequency Questionnaire
Self-completion 
questionnaire and self-
completion of Food 
Frequency Questionnaire
Face-to-face interview and 
self-completion of Food 
Frequency Questionnaire
Obtained sample 6,539 5,992 10,364
Response rate 62% 53% 62%
Source: SLAN (2008)
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On 25 June Minister John Curran released a new bulletin 
outlining drug prevalence data by regional drugs task force 
(RDTF) area based on fi ndings from the 2006/2007 national 
drug prevalence survey.1 Drug prevalence surveys of the 
general population are important in that they can shed 
light on the patterns of drug use, both demographically 
and geographically and, when repeated, can track changes 
over time. The Irish survey followed best practice guidelines 
recommended by the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA). 
As expected, the use of illegal drugs was lowest in the north 
west and highest in the east of the country (Table 1). 
Lifetime use
Cannabis was the most commonly reported illegal • 
drug in each of the RDTF areas, with proportions 
ranging between 13% in the North West and 36% in 
the East Coast areas (Table 2 and Figure 1). 
Ecstasy was among the four most commonly • 
reported drugs in each of the RDTF areas, with 
proportions ranging between 2% in the North West 
and 11% in North Dublin (Table 3). 
Cocaine was among the top four drugs ever used • 
by the survey respondents in all areas except the 
North West RDTF (Table 4). Lifetime cocaine use 
was highest in the North Dublin and East Coast 
RDTF areas. 
Poppers were among the four most commonly • 
used drugs in the north west of the country while 
amphetamines were among the more commonly 
used drugs in the south east. 
Though the proportions were small, there were signifi cant 
increases in lifetime use of cocaine in fi ve task force areas in 
2006/7 when compared to 2002/32 (Table 4). 
(Jean Long)
1. National Advisory Committee on Drugs and Drug and 
Alcohol Information and Research Unit (2008) Drug 
use in Ireland and Northern Ireland: results from the 
2006/2007 drug prevalence survey by regional drugs 
taskforce area. Bulletin 2. Dublin: National Advisory 
Committee on Drugs. 
2. National Advisory Committee on Drugs and Drug and 
Alcohol Information and Research Unit (2005) Drug use 
in Ireland and Northern Ireland: fi rst results (revised) from 
the 2002/2003 drug prevalence survey. Dublin: National 
Advisory Committee on Drugs.
Data from third SLAN survey (continued)
Drug use among the general population 
in regional drugs task force areas
In general, these data are not comparable to the results 
of the 2006/7 general population survey by the NACD as 
the SLAN survey excluded those between 15 and 17 and 
included those over 65 years.
In general, the use of confi dence intervals would allow 
commentators to rule out sampling variation when 
comparing the SLAN surveys, both over time, and with other 
surveys completed at the same time. 
(Jean Long)
1. Morgan K, McGee H, Watson D, Perry I, Barry M, Shelley 
E, Harrington J, Molcho M, Layte R, Tully N, van Lente 
E, Ward M, Lutomski J , Conroy R and  Brugha R (2008) 
SLÁN 2007: Survey of lifestyle, attitudes & nutrition in 
Ireland. Main report. Dublin: Department of Health and 
Children. 
2. Central Statistics Offi ce classifi cation by social class: 
1. Professional workers; 2. Managerial and technical; 
3. Non-manual; 4. Skilled manual; 5. Semi-skilled; 6. 
Unskilled.
Table 2 Last-year prevalence of illegal drug use in Ireland 
During last year Adults 18 years or over 
%
Males 18 years or over 
%
Females 18 years or over 
%
Illegal drug use* 6.0 9.0 4.0
Cannabis 5.0 8.0 3.0
Ecstasy 1.0 1.0 <1.0
Cocaine 1.0 2.0 <1.0
* Illegal drugs in this context are amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents.
Source: SLAN (2008)
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Drug use in RDTF areas (continued)
Table 1 Proportion of respondents who reported lifetime, last-year and last-month use of illegal drugs, by regional 
 drugs task force area of residence
Percentage that used any illegal drugs* 
RDTF area of residence Ever in lifetime In year prior to survey In month prior to survey
2002/3 2006/7 2002/3 2006/7 2002/3 2006/7
East Coast 25.9 38.4
† 6.3 12.4† 4.1 5.3
North Dublin City & County 29.5 32.2 8.4 12.8 5.3 8.2
South West (Dublin) 24.0 25.6 7.5 7.4 4.3 2.0
South East 18.5 25.4 6.9 7.9 3.1 3.6
North Eastern 18.9 22.9 6.4 5.7 2.4 1.1
Midland 11.0 19.6
† 2.8 4.4 1.0 1.7
Mid West 12.0 18.0 3.2 5.8 1.6 1.4
Southern 12.1 16.3 4.7 4.9 2.1 2.0
Western 12.5 23.3
† 2.9 4.7 1.9 1.6
North West 10.6 14.5 2.6 2.9 0.2 0.3
* Illegal drugs in this context are amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents.
†Signifi cant changes in proportion for the two survey periods.
Source: National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (2005, 2008)
Table 2 Proportion of respondents who reported lifetime, last-year and last-month use of cannabis, by regional drugs 
 task force area of residence
Percentage that used cannabis
RDTF area of residence Ever in lifetime In year prior to survey In month prior to survey
 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7
East Coast 24.5 35.9
† 6.1 11.3† 3.8 4.2
North Dublin City & County 26.9 28.8 7.7 11.9 4.5 7.9
South West (Dublin) 23.2 24.0 7.3 6.7 3.9 1.8
South East 16.8 23.3 5.8 5.1 2.1 2.8
North Eastern 17.8 19.5 5.2 4.6 1.9 0.8
Midland 10.7 17.0 2.8 4.1 1.1 1.1
Mid West 10.9 17.0 3.0 4.7 1.6 1.4
Southern 11.6 15.0 4.4 4.6 2.1 2.0
Western 12.0 21.0
† 2.0 4.3 1.3 1.6
North West 9.3 12.8 2.2 2.9 0.2 0.3
†Signifi cant changes in proportion for the two survey periods. 
Source: National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (2005, 2008) 
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Table 3 Proportion of respondents who reported lifetime, last-year and last-month use of ecstasy, by regional drugs 
 task force area of residence
Percentage that used ecstasy
RDTF area of residence Ever in lifetime In year prior to survey In month prior to survey
2002/3 2006/7 2002/3 2006/7 2002/3 2006/7
East Coast 5.4 7.6 2.5 2.3 0.9 0.5
North Dublin City & County 6.5 11.2 1.6 2.9 0.3 1.0
South West (Dublin) 5.9 4.1 1.3 0.5 0.0 0.0
South East 4.3 6.5 1.3 1.9 1.3 0.3
North Eastern 2.6 5.4 0.5 0.9 0.0 0.0
Midland 2.0 5.8
† 0.9 0.9 0.0 0.3
Mid West 1.7 2.9 0.6 0.8 0.0 0.3
Southern 2.8 3.5 0.9 0.6 0.2 0.2
Western 1.8 4.4 0.3 0.9 0.3 0.3
North West 0.3 2.2
† 0.0 0.3 0.0 0.3
†Signifi cant changes in proportion for the two survey periods. 
Source: National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (2005, 2008) 
Table 4 Proportion of respondents who reported lifetime, last-year and last-month use of cocaine, by regional drugs 
 task force area of residence
Percentage that used cocaine*
RDTF area 
of residence
Ever in lifetime In year prior to survey In month prior to survey
2002/3 2006/7 2002/3 2006/7 2002/3 2006/7
East Coast 6.3 9.1 2.3 3.1 0.5 0.8
North Dublin City & County 5.2 11.0
† 1.7 3.3 0.8 1.4
South West (Dublin) 5.0 3.8 1.5 0.8 0.6 0.3
South East 2.5 6.7
† 1.7 2.4 0.0 0.9†
North Eastern 1.2 5.6
† 0.0 1.5 0.0 0.0
Midland 1.3 4.4
† 0.3 1.7 0.3 0.9
Mid West 1.1 2.9 0.6 1.0 0.0 0.0
Southern 1.9 3.1 0.7 1.1 0.4 0.2
Western 1.6 3.5 0.7 1.5 0.4 0.4
North West 0.0 1.6
† 0.0 0.3 0.0 0.3
*Cocaine in this context is cocaine powder and crack. 
†Signifi cant changes in proportion for the two survey periods. 
Source: National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (2005, 2008)
Drug use in RDTF areas (continued)
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Drug use in RDTF areas (continued)
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Figure 1 Lifetime prevalence among the general population of the four most commonly used illegal drugs in 
Ireland, by regional drugs task force area, 2006/7 
Cannabis 12.8%
Ecstasy 2.2%
Magic mushrooms 3.0%
Poppers 2.6%
Cannabis 19.5%
Cocaine 5.6%
Ecstasy 5.4%
Magic mushrooms 5.0%
Cannabis 21.0%
Cocaine 3.5%
Ecstasy 4.4%
Magic mushrooms 3.2%
Cannabis 17.0%
Cocaine 2.9%
Ecstasy 2.9%
Magic mushrooms 3.1%
Cannabis 35.9%
Cocaine 9.1%
Ecstasy 7.6%
Magic mushrooms 10.5%
Cannabis 17.0%
Cocaine 4.4%
Ecstasy 5.8%
Magic mushrooms 5.5%
Amphetamines 6.9%
Cannabis 23.3%
Cocaine 6.7%
Ecstasy 6.5%
Cannabis 28.8%
Cocaine 11.0%
Ecstasy 11.2%
Magic mushrooms 11.4%
Cannabis 24.0%
Cocaine 3.8%
Ecstasy 4.1%
Magic mushrooms 5.4%
Cannabis 15.0%
Cocaine 3.1%
Ecstasy 3.5%
Magic mushrooms 3.4%
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The fi fth annual RADE (Recovery through art, drama 
and education) showcase of creative work produced by 
recovering drug users took place in May of this year. 
Established in August 2004, RADE‘s purpose is ‘to train 
participants in arts activities designed to facilitate and 
encourage them in progression routes such as employment, 
further education and training’.1 These participative 
programmes involve some of Ireland’s leading contemporary 
artists from all artistic mediums. The event was opened by 
the then Minister of State Pat Carey TD in the Project Arts 
Centre in Temple Bar. 
Ken Farrell and Christine Dempsey commenced by reciting 
their creative writing works entitled Two Different Worlds, 
which will feature in RADE’s forthcoming book. This was 
followed by the world premier of Raiders of the Lost Art. This 
play, written and directed by RADE manager Michael Egan, 
blended myth with modern reality in a comic and vibrant 
fashion. An adaptation of the Táin Bó Cúailnge, it also served 
as the inspiration for the samples of art work and clips from 
a forthcoming documentary which were also on display. 
The art work is in preparation for an exhibition that will take 
place in Dublin Civic Offi ces from 30 June to 4 July. 
The healing power of expression through creativity has 
recently gained increased attention.2 Minister Carey spoke 
of this form of recovery as a useful ‘agent for change’ which 
harnesses both the strengths and weaknesses of a person’s 
character. Referring to the current revision of the National 
Drugs Strategy, he stressed the need for innovation in 
order to help former drug users realise their ‘highest levels 
of functional ability.’  He reiterated this focus on original 
thinking required: ‘Let’s not be looking back, let’s always 
look forward.’ Michael Egan praised his cast, stressing the 
application of discipline, focus and attention that the play 
demanded. He closed by defi ning the programme as an 
‘alternative to other activities that drag you down’. 
(Caroline Forde)
1. Further information is available on the RADE website at 
www.rade.ie. See also Connolly J (2007) President opens 
RADE’s cultural showcase. Drugnet Ireland, Issue 22: 5.
2. Friend F (2008) Complementary therapy: creative 
writing. Drink and Drugs News, 21 April 2008: 12–13.
Upcoming RADE events:
RADE Art Exhibition on 30 June, 1.00 pm, 
Dublin City Council Civic Offi ces, Wood Quay, Dublin 8. 
Admission free. The exhibition is running for a week.
Raiders of the Lost Art on 14, 15, 17 and 18 July at 2.30 pm, 
Ballyfermot Civic Centre, Ballyfermot. 
Tickets €8. Call 01 454 8733.
Healing through creativity: RADE’s 
cultural showcase  
Alcohol Advisory Group reports  
The Government Alcohol Advisory Group presented its 
report to the (then) Minister for Justice Brian Lenihan on 23 
April 2008.1 This Group was set up to examine key aspects of 
the law governing the sale and consumption of alcohol. 
The issues examined by the Group were:
the increase in the number of supermarkets,  ■
convenience stores and petrol stations with off-licences, 
and the manner and conditions of sale of alcohol 
products in such outlets, including below-cost selling 
and special promotions; 
the increasing number of special exemption orders  ■
which permit longer opening hours being granted to 
licensed premises around the country; and 
the use, adequacy and effectiveness of existing sanctions  ■
and penalties, particularly those directed towards 
combating excessive and underage consumption. 
The report highlights recent trends in alcohol consumption, 
public health and public order. It states that Ireland has one 
of the highest levels of alcohol consumption in the European 
Union, with levels in 2006 about 30% higher than the 
EU average. The number of people admitted to hospitals 
intoxicated or drunk rose to a peak in 2002, in line with a 
peak in alcohol consumption. Such admissions increased 
by 76% between 1997 and 2002. In 2006, approximately 
60,000 proceedings were taken under the Criminal Justice 
(Public Order) Act 1994.
Michael Egan, RADE Manager, with Minister Carey 
(Photo: JJ Berkeley) 
Members of the cast of RADE’s Raiders of the Lost Art 
(Photo: Evin McCarthy) 
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Recommendations of the Group
The report makes thirty-one recommendations, under four 
headings, including: 
General
The specifi c properties of alcohol are recognised in • 
public policy-making and the consequences which 
fl ow from that recognition be taken into account in 
decision-making across the public policy spectrum.
An overall national strategy on alcohol is developed • 
and implemented with a coherent approach across 
government departments and other public bodies.
Sale of alcohol
Applicants for a wine-retailer’s off-licence are required • 
to produce a District Court Certifi cate to the Revenue 
Commissioners.
The grounds on which objection may be made to the • 
granting of District Court Certifi cates for spirit, beer 
and wine off-licences are extended to include the 
suitability of licensed premises for the needs of local 
residents and the adequacy of the existing number of 
licensed premises in the neighbourhood.
Off-sales of alcohol are restricted to the hours of • 
10.30am to 10.00pm, including Sundays, in the case 
of off-licences and mixed trading premises.
Structural separation of alcohol products from • 
non-alcohol products in mixed trading premises is 
introduced.
The minimum age for selling alcohol in off-licences • 
and mixed trading premises is increased to 21 years.
A statutory provision to permit test purchasing of • 
alcohol by persons under the age of 18 years is 
enacted.
The District Court is authorised to insist upon an • 
adequate CCTV system as a condition for the grant 
of a certifi cate, or renewal of a licence, in respect of 
an off-licence or mixed trading premises.
Alcohol products are priced and sold on the basis • 
of a unit price; this is intended to prohibit alcohol 
promotions and sales involving price discounts and 
‘2 for 1’ offers.
Extended trading hours
Special exemption orders granted to nightclubs and • 
late bars are to comply with fi re safety standards and 
determination by the Court of maximum occupancy 
levels. 
The current statutory extended time limit of 2.30 am • 
is changed to 2.00 am.
The District Court does not grant a special • 
exemption order for any premises unless satisfi ed 
that the special occasion will be conducted in a 
manner that will not cause undue inconvenience or 
nuisance to people living in the locality, or create an 
undue threat to public order or safety.
Premises with theatre licences are subject to the • 
general time limits applicable to public houses.
The granting of general exemption orders which • 
permit early opening for premises located in the 
vicinity of fairs and markets is repealed.
Sanctions, penalties and enforcement
Fines for offences involving drunkenness, disorderly • 
conduct and the provision of alcohol to under-age 
people is increased towards maximum District 
Court levels.
A minimum closure period of two days is applied • 
in the case of temporary closure orders for a fi rst 
offence.
While these recommendations have been put forward to the 
Minister, they may not all be drafted into legislation. When 
announcing the establishment of the Group, the Minister 
also signalled that work would continue on the drafting of 
a comprehensive Sale of Alcohol Bill, which is included in 
the government’s legislation programme for 2008. This Bill 
will modernise and streamline the laws relating to the sale 
and consumption of alcohol by repealing the Licensing Acts 
1833 to 2004, as well as the Registration of Clubs Acts 1904 
to 2004, and replacing them with updated provisions. 
(Deirdre Mongan)
1. Government Alcohol Advisory Group (2008) Report of the 
Government Alcohol Advisory Group. Dublin: Department 
of Justice, Equality and Law Reform. 
Alcohol-related harm in Ireland  
The Health Service Executive (HSE) recently published 
Alcohol-related harm in Ireland, by Dr Ann Hope.1 The report 
provides an overview of more than 30 recent studies and 
outlines the rising trends in alcohol consumption rates, and 
the harmful effects on the user and on other people. It looks 
at 60 factors relating to problem alcohol use, including 
health, workplace absences, pregnancy, domestic abuse, 
public order offences and road crashes.
The report makes it clear that alcohol-related harm is 
not confi ned to the drinker, but extends to the family, 
community and wider society. It describes the burden of 
harm to others, including public violence in the form of 
physical assaults, homicide, domestic violence and road 
injuries. Key fi ndings presented in the report are shown 
below.
Alcohol-related harm to the drinker
28% of all injury attendances in Accident and Emergency  ■
departments in acute hospitals were related to alcohol. 
Alcohol-related hospital discharges increased by 92%  ■
between 1995 and 2002.
Incidence rates for cancer of the liver had the highest  ■
increase of all cancer rates between 1994 and 2003. 
The number of new alcohol-related cancers will more  ■
than double for females and increase by 81% for males 
in the period 2005 to 2020. 
Alcohol affects an adolescent brain differently from  ■
an adult brain and damage from alcohol use during 
adolescence can be long term and irreversible. 
Alcohol Advisory Group reports (continued)
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Almost half of men and over a quarter of women agreed  ■
that drinking alcohol had contributed to their having 
had sex without contraception. 
Between 1995 and 2004, sexually transmitted infections  ■
(STIs) increased by 217%. 
Alcohol was a contributory factor in 36.5% of all fatal  ■
crashes in 2003. 
Between 1996 and 2002, public order offences by  ■
adults increased by 247% (from 16,284 to 56,822); 
they decreased in 2003 and 2004 but increased again 
in 2005. 
Alcohol-related harm to others
Almost half (46%) of those who committed homicide  ■
were intoxicated at the time. 
Between 1990 and 2006, 2,462 people were killed  ■
on the roads between 9 pm and 4 am, the time most 
associated with alcohol-related accidents. 
In a general population survey, 44% of all respondents  ■
had experienced harm caused by their own or someone 
else’s alcohol use. 
A study of college students found that almost two-thirds  ■
of male and over half of female students reported that 
they had experienced at least one incident of harm as a 
consequence of someone else’s alcohol use. 
In a quarter of severe domestic abuse cases, alcohol was  ■
involved. 
The Coombe Women’s Hospital found that 63% of  ■
women reported alcohol use during pregnancy, with 7% 
drinking six or more drinks per week. 
A survey of employers found that alcohol-related illness  ■
was cited by 12% of companies as a cause of short-term 
absence from work by males, and by 4% of companies 
as a cause of absence by females.
The report acknowledges that the fi ndings paint a grim 
picture of the increasingly negative role played by alcohol in 
Irish society, which has major implications for policy makers, 
especially in the areas of health, justice and social policy. It 
calls for a set of integrated policies to reduce alcohol-related 
harm. It points out that the Strategic Task Force on Alcohol 
(STFA) provided the template for reducing alcohol-related 
harm in Ireland based on scientifi c evidence, but that there 
is no national structure with measurable targets and time-
lines in place to implement the STFA recommendations. 
A number of areas are identifi ed where immediate action 
is required: 
Effective policy – a set of integrated policies, based • 
on effectiveness and cost effectiveness in reducing 
alcohol-related harm 
National structure – an agency or body taking • 
responsibility for alcohol policy implementation, such 
as happens with drugs and tobacco 
Quality data systems – effective monitoring of • 
alcohol-related harm needs quality data gathering 
across a range of alcohol-harm indicators, and many 
gaps still exist. 
The report concludes that alcohol-related harm is complex 
and multifaceted and will not be reduced unless action 
is taken. The dramatic increase in alcohol-related harm 
does not bode well for the future health and well-being of 
the population in Ireland. Ireland is moving in the wrong 
direction, alcohol harm must be signifi cantly reduced. 
Delaying the necessary action increases the growing burden 
of harm for everyone in society. 
(Deirdre Mongan)
1. Hope A (2008) Alcohol-related harm in Ireland. Dublin: 
Health Service Executive – Alcohol Implementation 
Group.
New alcohol advertising codes
The Government has announced its decision to strengthen 
the measures in place to control alcohol advertising.1 
New advertising codes have been negotiated between the 
Department of Health and Children and representatives 
from the Irish alcohol and advertising industries. The 
purpose of these codes is to reduce the exposure of young 
people to alcohol advertising and marketing, and to limit the 
overall level of alcohol advertising and sponsorship across all 
Irish media. 
Under the new measures:
Alcohol advertising will not be permitted unless the • 
relevant medium has an adult audience profi le of 
greater than 75%, rather than 67% as currently applies. 
Where alcohol advertising is permitted, it will be • 
limited to no more than 25% of available space or 
time on any occasion. 
No alcohol advertising slots or messages from • 
sponsors before the normal ad breaks in sports 
programming (known as ‘stings’) will be allowed. 
Breakfast-time television (6–10 am) will be treated as • 
children’s viewing time and will not carry any alcohol 
advertising. 
All alcohol advertisements must be vetted and carry • 
the Central Copy Clearance Ireland (CCCI) stamp of 
approval before acceptance by any media. 
A new consultative group will be established to • 
advise and consult with the chairman of the Alcohol 
Marketing Communications Monitoring Body 
(AMCMB), which will allow a wider stakeholder 
involvement in the monitoring process. 
The revised codes will be published shortly and will be 
operational by the summer. They will be reviewed by the 
AMCMB, which will have responsibility for monitoring 
compliance with the new codes.
(Deirdre Mongan)
1. Department of Health and Children (2008) Minister 
Gallagher announces strengthened measures to 
control alcohol advertising. Press release, 24 April. 
Retrieved 28/04/2008 from www.dohc.ie/press/
releases/2008/20080424.html 
Alcohol-related harm (continued)
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Teenagers discuss solutions to 
alcohol misuse
A national consultation was undertaken by 
the Offi ce of the Minister for Children and the 
Department for Health and Children in 2007 in 
order to investigate the views of teenagers in 
relation to problem alcohol use.1 This consultation 
was on foot of the commitment by the Department 
of Health and Children to involve children and 
young people in researching their own lives, as 
highlighted in the National Children’s Strategy 
2000–2010.2
The consultation involved 257 Irish teenagers 
(aged 12–18) from secondary schools, youth 
organisations, Youth Reach centres and special 
interest groups. Five consultations were held, one 
each in Athlone, Sligo and Cork and two in Dublin. 
Workshops were facilitated by adults and some co-
facilitated by young people from the Children and 
Young Peoples Forum (CYPF). 
The consultation process involved the preliminary 
identifi cation of solutions to problem alcohol use, 
which informed the themes for each workshop, and 
were then discussed by all participants at a Plenary 
session. There was considerable consistency in the 
themes identifi ed at each consultation. The four 
main solutions identifi ed were: a reduction in the 
legal age for drinking alcohol, alternative alcohol-
free facilities, education, and law enforcement. The 
fi rst two themes were noted as the most important 
by the teenage participants. 
A small number of participants favoured raising 
the legal age limit to 21 years, while the majority 
favoured allowing 16–18-year-olds to drink in 
moderation under the monitoring of a ‘safe-
limit’ card. A ‘safe-limit’ card would allow young 
people over the age of 16 a ‘safe number’ of 
alcoholic drinks of any type per night. They also 
recommended allowing those under the age of 
16 to drink alcoholic beverages with less than 5% 
alcohol content. Participants reported that it would 
be more sociable and safer for young people to 
drink in public houses rather than covertly in public 
places. This would facilitate surveillance and reduce 
the ‘buzz’ surrounding teenage drinking which 
is enhanced by the illicit nature of the activity. 
Participants spoke of the necessity for an enforced 
system of identifi cation for 12–25-year-olds. It was 
felt that only one form of identifi cation should be 
accepted, such as the Garda Age Card, and that 
there was a clear need for tougher penalties for 
under age drinking. 
The provision of affordable, alcohol-free facilities 
was an important solution highlighted by 
participants. While youth cafés were noted as 
a potential means of reducing the demand for 
alcohol-based recreation, it was noted that this 
would not fully eradicate the demand for alcohol 
among teenagers. It was argued that such facilities 
must have considerable teenage input in both their 
development and review. 
Sport was noted as a vital area for developing 
alternative activities through both the strategic 
timing of activities (e.g. Saturday and Sunday 
mornings, thus hindering drinking behaviour on 
weekend nights) and increasing their inclusive 
focus, whereby participation is not restricted to a 
talented minority. 
Participants identifi ed a defi cit in information 
relating to the consequences of problem alcohol 
use and felt that the delivery of age-appropriate 
material by objective professionals, rather than 
by teachers, could help greatly in addressing this 
defi cit. It was noted that responsible drinking, 
rather than abstinence, was a more realistic 
approach for participants and that peer-mentoring 
and the use of role-models who drink responsibly 
could improve current alcohol education 
programmes. The role of parents was identifi ed 
as important in underpinning education-based 
solutions, whereby a relationship of mutual respect, 
guidance and role modelling was paramount in 
fostering an attitude of responsibility towards 
alcohol use among teenagers. 
While this report offers insights into teenagers’ 
opinions, their recommendations for reducing 
problem alcohol use are in confl ict with those 
advocated by the World Health Organization 
– regulating availability and increasing prices – 
which have been proven as the most effective 
policy interventions. It also appears that the 
teenagers were not informed of the effectiveness 
of potential solutions prior to the consultation; if 
this information had been provided, the strategies 
recommended might have been different. 
(Sarah Gibney) 
1. Department of Health and Children (2008) 
Teenagers’ views on solutions to alcohol misuse. 
Dublin: Stationery Offi ce.
2. Department of Health and Children (2000) 
National Children’s Strategy: our children – their 
lives. Dublin: Stationery Offi ce.
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As Ireland’s National Drugs Strategy (NDS) 
2001–2008 is being reviewed, it is useful to 
consider how the research infrastructure has 
developed during this period and what contribution 
research has made to achieving the Strategy’s aim 
to have ‘valid, timely and comparable data on the 
extent and nature of drug misuse in Ireland’. 
Information providers
For several years prior to the NDS the National 
Drug Treatment Reporting System (NDTRS), 
maintained by the Drug Misuse Research Division 
(DMRD, now called the Alcohol and Drug Research 
Unit, ADRU) of the Health Research Board (HRB), 
was the main source of information on drug misuse 
in Ireland and the DMRD supplied the EU with the 
data required for comparative analysis of the drug 
situation in the member states. In the year prior 
to the launch of the NDS, the National Advisory 
Committee on Drugs (NACD) was established to 
address remaining research and information gaps. 
Together with the DMRD, the NACD was given 
responsibility for providing the quality information 
and the comprehensive and comparable data 
essential to the delivery of a successful drugs 
strategy and to fulfi lling Ireland’s commitment to 
the EU in this area.1
Developments in research during the lifetime of the 
NDS are considered below.
Prevalence data1.  – The NDS Review Group 
recognised the limitations of methods which 
extrapolated from treatment fi gures, and from 
statistics on drug-related arrests and deaths, to 
produce estimates of the prevalence of opiate 
use. A major task facing the NACD at the 
time was to determine how best the size and 
nature of the drug problem in Ireland could 
be measured. In 2005 the NACD published 
the fi ndings of a major survey of households 
in Ireland and Northern Ireland carried out 
in 2002/2003. This survey was repeated in 
2006/2007 and the results published in 2008. 
The NACD has also commissioned studies on 
drug prevalence among vulnerable groups, 
including the homeless, new communities in 
Ireland and Travellers.
Treatment data2.  – The NDS Review Group 
recommended changes to ensure that 
treatment facilities reported problem drug 
use to the DMRD (now ADRU) in order to 
improve the effi ciency and quality of fl ow 
of this information. The ADRU manages the 
National Drug Treatment Reporting System 
(NDTRS), an anonymised epidemiological 
database that records demand for treatment for 
problem alcohol and drug use. The NDTRS is 
one of two national registers that record drug 
treatment in Ireland; the other is the Central 
Treatment List (CTL), an administrative database 
used to regulate the dispensing of methadone 
treatment. The CTL is a complete register of all 
patients receiving methadone (as treatment for 
problem opiate use) in Ireland. 
Following a review of the NDTRS a concerted 
effort was made to improve the completeness 
and accuracy of recorded data from 2001.2 In 
early 2008 the HRB was able to publish trends 
in treated drug use across Ireland between 
2001 and 2006. In 2006 the NACD published 
the results of a longitudinal study evaluating 
the effectiveness of drug treatment (ROSIE). 
This study found that there was a signifi cant 
reduction in heroin and other drug use one year 
after treatment uptake.
Drug-related deaths3.  – The NDS recommended 
that Ireland should develop a dedicated system 
for recording drug-related deaths, a capacity 
essential for comparative analysis with other 
countries. The NDS envisaged that this task 
would be undertaken by the Central Statistics 
Offi ce (CSO), who had responsibility for 
maintaining the General Mortality Register. 
However, in 2005 the ADRU, on behalf of the 
departments of Justice and Health, established 
the National Drug-Related Deaths Index 
(NDRDI), a census of drug-related deaths 
(such as those due to accidental or intentional 
overdose) and deaths among drug users (such 
as those due to hepatitis C and HIV). The 
NDRDI is a multi-source index, extracting and 
matching data from coroners’ fi les, the CTL, the 
Hospital In-Patient Enquiry Scheme (HIPE), and 
the General Mortality Register. 
Drug-related infectious diseases (HIV, 4. 
hepatitis) – The NDS Review Group used 
statistics compiled by the Department of Health 
and Children as the main source of information 
on HIV and hepatitis infection among drug 
users in the general population. Two major 
reports provided a detailed picture of the 
prevalence of drug-related infectious diseases in 
prisons. There have been some developments 
in this area during the lifetime of the NDS. The 
Health Protection Surveillance Centre (HPSC) 
introduced an extended surveillance system 
for hepatitis B in 2004 and for hepatitis C in 
2007. In 2006 the HRB published an overview 
on blood-borne viral infections among injecting 
drug users in Ireland between 1995 and 2005. 
However, there has been no concerted effort 
to monitor the incidence and prevalence of 
hepatitis B, hepatitis C or HIV among drug users 
since the NDS was launched. 
Drug-related arrests and offences and drug 5. 
seizures – The annual reports of the Garda 
Síochána were the source of information on 
drug-related arrests and offences and on 
seizures referred to by the Review Group. 
Since then, improved data management by 
Garda authorities has led to improvements in 
the quality of these data. The Garda Síochána 
Act 2005 transferred responsibility for the 
Drug-related research in Ireland 
2001–2008
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CSO report: drug-crime statistics
Until 2006, the principal source of information on 
drug offences was the annual reports of the Garda 
Síochána. In 2006, responsibility for reporting crime 
statistics was transferred to the Central Statistics 
Offi ce (CSO). 
On 28 January this year the CSO issued Headline 
crime statistics: quarter 4 2007.1 This quarterly 
report compared the headline crime statistics for 
quarter four of 2006 and 2007, using the old Garda 
headline crime classifi cation system. On 17 April 
the CSO introduced a new Irish Crime Classifi cation 
System (ICCS), together with an overview 
summarising the history of the former headline 
classifi cation system and the rationale behind the 
new system. On 23 April the CSO published Garda 
recorded crime statistics, 2003–2006, based on the 
new ICCS.2 This was accompanied by a briefi ng 
document, Interpreting crime statistics, issued on 
25 April, which explained the sources used and 
the diffi culties encountered in relation to crime 
classifi cation. The fi ndings of the 28 January and 23 
April reports are described in this article. 
Garda recorded crime statistics provides an 
overview of the background to its publication and 
framework. It also outlines the revisions made 
to the recording of crime data on the PULSE 
system (Police Using Leading Systems Effectively), 
the counting rules used in relation to crimes 
committed, issues around the detection of crime 
and the interpretation of court proceedings. 
There are also a number of selected features, 
including the breakdown of recorded controlled 
drug offences by city. Appendix II of the report 
presents details of the Garda Síochána Diversion 
Programme.
The vast majority of drug offences reported come 
under one of three sections of the Misuse of 
Drugs Act (MDA) 1977: section 3 – possession of 
any controlled drug without due authorisation 
compilation and publication of recorded 
crime statistics from An Garda Síochána to 
the CSO. In 2008 the CSO adopted a new 
classifi cation system for criminal offences in its 
new publication Garda recorded crime statistics 
2003–2006. The new system includes a distinct 
category of ‘controlled drug offences’, broken 
down into three sections covering supply, 
possession and other drug offences. 
Developments under the last of these indicators are 
a good example of how the increase in research 
and information-gathering capacity since 2001 
in certain areas can affect capacity in apparently 
unrelated areas. For instance, the NACD’s selection 
of drugs and crime as a priority area and its 
decision to support specifi c research projects in 
this fi eld, including a major study on drug markets, 
were based on evidence derived from the ROSIE 
study, research on vulnerable groups mentioned 
above, community studies and drug trend 
monitoring, as well as on specifi c studies on drugs 
and crime undertaken by the HRB. 
The fi rst years of the new drugs strategy will see 
more of this cross-fertilisation as information from 
dedicated prevalence studies, more comprehensive 
and accurate treatment demand data and drug-
related deaths data are published and assimilated 
and we come closer to closing the information 
gaps identifi ed by the NACD.3 The bodies charged 
with implementing the actions under the various 
pillars of the new strategy will thus be able to work 
in a much richer information environment than 
prevailed in 2001. 
(Brian Galvin and Louise Farragher)
1. The HRB and NACD publications referred to 
are available on the organisations’ websites at 
www.hrb.ie and www.nacd.ie. 
2. Kavanagh P, Long J and Barry J (2006) 
Completeness and accuracy of the drug 
treatment reporting system in Dublin, Ireland. 
Irish Journal of Medical Science, 175 (3): 52–56.
3. In its 2005–2008 business plan the NACD 
matched its work programme to most of 
the gaps identifi ed by the Interim Advisory 
Committee on Drugs in 2000. Most of the 
remaining gaps relate to criminal justice issues 
and cost effectiveness in delivery of treatment, 
prevention and other interventions.
Offence type
Possession for sale 
or supply
Cultivation, manufacture 
or importation
Obstruction
2006 3,025 135 472
2007 3,620 214 589
% Increase 19.7 58.5 24.8
Source:  CSO (2008a)
Table 1 Annual total headline drug offences, 2006 and 2007 
Drug-related research (continued)
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(simple possession); section 15 – possession of a 
controlled drug for the purpose of unlawful sale 
or supply (possession for sale or supply); and 
section 21 – obstructing the lawful exercise of a 
power conferred by the Act (obstruction). Other 
MDA offences regularly recorded relate to the 
unlawful importation into the State of controlled 
drugs (section 21); permitting one’s premises to 
be used for drug supply or use (section 19); the 
use of forged prescriptions (section 18); and the 
cultivation of cannabis plants (section 17).3 
Table 1 displays total headline offences in the drugs 
category for the years 2006 and 2007. Increases 
were recorded in all such offences in 2007, with 
an overall increase of 791 (21.8%). The offence of 
cultivation, manufacture or importation of drugs, 
while the lowest in the category, showed the largest 
percentage increase (58.5%) in 2007. Possession 
of drugs for sale or supply, representing the largest 
offence type in the drugs category, increased by 
595 (19.7%). 
Figure 1 shows trends in relevant legal proceedings 
for possession and supply between 2003 and 
2006.4 The majority of these proceedings are for 
drug possession, which have risen since 2003 and 
accounted for 68.4% of drug offence proceedings 
in 2006. The number of relevant legal proceedings 
for supply offences in 2006 was 2,291, representing 
25.7% of total drug offence proceedings. 
Figure 2 shows trends in relevant legal proceedings 
for a selection of other drug offences between 2003 
Figure 2 Trends in relevant legal proceedings for selected MDA offences, 2003–2006 
Source: CSO (2008b)
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Drug crime statistics (continued)
Figure 1 Trends in relevant legal proceedings for possession (s.3 MDA), supply (s.15 MDA) and 
total drug offences, 2003–2006 
Source: CSO (2008b)
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Figure 3 Trends in proceedings for possession of drugs, by selected drug types, 2003–2006 
Source: CSO (2008b)
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Drug crime statistics (continued)
Figure 4 Trends in total proceedings for possession and those for cannabis-type substances, 
2003–2006 
Source: CSO (2008b)
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and 2006. Obstruction offences increased steadily 
from 208 in 2003 to 349 in 2006. Following a 
two-year decline, relevant legal proceedings for 
cultivation or manufacture of drugs increased 
during 2006 to slightly above the 2003 fi gure. 
Figure 3 shows trends in proceedings for 
possession of drugs, by drug type, for a selection 
of substances between 2003 and 2006.5 Both 
heroin and cocaine show steady increases since 
2003, with heroin increasing by 47.7% between 
2005 and 2006. Following a 38% decline over two 
years, proceedings for possession of ecstasy-type 
substances increased by 35% between 2005 and 
2006, almost reaching their 2003 level. 
Figure 4 shows trends in total proceedings for 
possession and those for cannabis-type substances 
between 2003 and 2006. Cannabis-type substances 
consistently accounted for the majority of these 
proceedings, representing 6,947 (49.6%) of the 
total in 2006.
Table 2 provides a breakdown of events that 
take place once an incident of a controlled drug 
offence is recorded in the PULSE system. The 
table is based on the 2006 data and includes the 
new ICCS references. The data provided in Table 
2 enhance our understanding of the operation 
of the criminal justice system. Of the 67 cases of 
importation/manufacture of drugs in which court 
drugnet 
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CSO report: illicit drug market statistics
The report, Garda recorded crime statistics 2003–2006, 
published by the Central Statistics Offi ce (CSO) in April 
provides data which can assist us in understanding aspects 
of the operation of the illicit drug market in Ireland.1 With 
regard to the so-called middle market level, which involves 
the importation and internal distribution of drugs, data on 
drug supply offence prosecutions by Garda division are a 
possible indicator of national drug distribution patterns.2 
While these data primarily refl ect law enforcement activities 
and the relative ease of detection of different drugs, they 
may also provide an indicator of national drug distribution 
trends. This data can be compared with drug treatment 
data, to show us whether the heroin trade is growing 
outside the Dublin region for example (see p.2 of this 
issue). Such data can also provide an indicator of traffi cking 
patterns by showing, for example, whether there is a 
concentration of prosecutions along specifi c routes. Figure 
1 shows the number of relevant legal proceedings for 
drug supply offences by Garda region outside the Dublin 
Metropolitan Region (DMR).3
The upward trend since 2004 in relevant legal proceedings 
for drug supply continued in 2006 (Figures 1 and 2). 
Although the majority of such proceedings still take place 
in the DMR, the proportion of the total number which take 
place outside the DMR has increased since 2004 (Figure 2). 
The number of drug seizures in any given period can be 
affected by such factors as law enforcement resources, 
strategies and priorities, and by the vulnerability of traffi ckers 
to law enforcement activities. However, drug seizures 
are considered as indirect indicators of the supply and 
availability of drugs. 
Cannabis seizures account for the majority of all drugs 
seized. Of the 8,417 reported drug seizures in 2006, 4,243 
(50.4%) were cannabis-related. Figure 3 shows trends 
in seizures for a selection of drugs, excluding cannabis, 
between 2003 and 2006. We can see a continuous steady 
rise in cocaine seizures since 2003. Heroin seizures rose 
sharply during 2006, increasing from 763 in 2005 to 1,254 
in 2006. The number of seizures of ecstasy-type substances 
also rose in 2006, following a steady decline since 2003. 
(Johnny Connolly and Caroline Forde)
1. Central Statistics Offi ce (2008) Garda recorded crime 
statistics 2003–2006. Dublin: Stationery Offi ce. 
2. Connolly J (2005) The illicit drug market in Ireland. 
Overview 2. Dublin: Health Research Board. See also 
Connolly J (2007) Drug-crime statistics. Drugnet Ireland, 
Issue 23: 16–18.
3. The report uses the term ‘relevant proceedings’ which 
refers to the legal proceedings, such as prosecution, 
taken in relation to the offence as it was originally 
recorded in the PULSE system. 
Table 2 Incidents recorded, resultant proceedings and outcomes for offences, 2006
Offence type Recorded With 
relevant 
proceedings
Court 
proceedings 
commenced
Conviction Proved & 
order made 
without 
conviction/ 
Probation of 
Offenders Act
Non-
conviction
Pending 
(incl. 
appeals 
allowed)
Controlled drug 
offences (10)
14,233 8,924 5,762 2,676 428 757 1,901
Importation or 
manufacture of 
drugs (101)
135 86 67 29 5 3 30
Possession of 
drugs (102)
13,488 8,398 5,353 2,507 413 704 1,729
Other drug 
offences (103)
610 440 342 140 10 50 142
Source: CSO (2008b)
Drug crime statistics (continued)
proceedings commenced, 29 resulted in a conviction and 
30 were pending. Of the 5,353 possession cases in which 
proceedings commenced, 2,507 resulted in conviction and 
1,729 were pending. 
(Johnny Connolly and Caroline Forde)
1. Central Statistics Offi ce (2008a) Headline crime statistics: 
quarter 4 2007. Dublin: CSO. 
2. Central Statistics Offi ce (2008b) Garda recorded crime 
statistics 2003–2006. Dublin: Stationery Offi ce. 
3. See also Connolly J (2007) Drug-crime statistics. Drugnet 
Ireland, Issue 23: 16-18. 
4. ‘Relevant proceedings’ refers to the legal proceedings, 
such as prosecution, taken in relation to the offence as it 
was originally recorded in the PULSE system. 
5. ‘Proceedings’ is a list of charges and proceedings 
which do not necessarily relate to the offence as it was 
originally recorded in the PULSE system. 
16
drugnet 
IRELAND
Figure 1 Drug supply (s.15 MDA) offences outside the Dublin Metropolitan Region where 
relevant legal proceedings commenced, 2003–2006
Source: CSO (2008)
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Figure 2 Trends in total number of relevant legal proceedings for supply offences and those in 
the Dublin Metropolitan Region, 2003–2006 
Source: CSO (2008)
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Figure 3 Trends in the number of seizures of selected drugs, excluding cannabis, 2003–2006 
Source: CSO (2008)
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Community detoxiﬁ cation pilot 
scheme
A series of seminars was held on 8 April with health 
care professionals and community and voluntary 
groups to introduce intra-agency community 
methadone detoxifi cation protocols. It aimed to 
give opportunities for discussion around offering 
community detoxifi cation as a viable alternative 
option for people. The then Minister of State Pat 
Carey TD also addressed the participants. 
These protocols will be piloted in the North 
Inner City Drugs Task Force (NICDTF) area over 
the next 18 months. They aim to provide an 
option for people who fi nd it diffi cult to take up a 
residential detoxifi cation bed due to family or work 
commitments. They may also benefi t individuals 
who want to reduce their methadone dosage in 
order to access a residential programme. They 
were developed in response to concerns voiced 
by the community and by drug users that people 
were being ‘parked’ on long-term methadone 
maintenance.
These protocols are based on best practice 
guidelines from the UK and input from Irish experts. 
They emphasise empowerment – drug users are 
empowered to choose what treatment option 
best suits them, but also to take responsibility for 
their treatment. The protocols are designed to 
address the concerns of GPs about the risk factors 
associated with the process, including integrating 
the necessary social support for their patient for a 
successful and safe detoxifi cation.
Overview of process 
Assessment – When the client expresses an interest 
in undertaking the programme, the process starts 
with an assessment (including history of drug 
misuse which may also require testing). The client 
needs to provide one month’s clean urine (free 
from opiates and illicit use of prescription drugs) 
and sign a consent form. 
Meetings are held with the client, their case 
manager and GP to explain the process, clarify roles 
and responsibilities, and provide education on the 
dangers of relapse and overdose in detoxifi cation. 
If the urinalysis shows non-compliance, in special 
circumstances and on agreement between all 
parties, the detoxifi cation may go ahead.
The case manager – The case manager’s role is 
important as it provides the social support essential 
for a successful and safe detoxifi cation outside 
a residential facility, which the GP alone cannot 
provide. The case manager is responsible for 
assessing the client’s suitability for the programme 
and for ensuring that correct protocols are 
followed. He/she has primary responsibility for the 
client’s care plan. In consultation with the client, 
the case manager will develop a relapse-prevention 
and aftercare plan, and will work with the client 
during and after the detoxifi cation (for a minimum 
of six months). 
The client – Clients wishing to undergo a 
community detoxifi cation also have responsibilities 
under the protocol. As well as providing clean urine 
samples, they must show willingness to engage 
regularly and reliably with their case manager 
and treatment agency. They must also commit to 
inform the case manager if they relapse or wish to 
stop the detoxifi cation.
Contra-indications
Previous history of epileptic seizures while  ■
undergoing detoxifi cation 
Dual addiction, where both addictions are  ■
unstable or where a second addiction other 
than opiates is uncontrolled 
Severe mental health problems that are  ■
currently untreated 
Major medical illness  ■
Active treatment for hepatitis C  ■
Pregnancy ■
Example of methadone detoxifi cation schedule 
Reduce methadone intake by 5ml per week  ■
until client reaches 50ml
Continue at 50ml for one month, then ■
Reduce by 3–5ml per week until client  ■
reaches 20ml
Continue at 20ml for one month (attempt  ■
to transfer to community pharmacist where 
possible), then 
Reduce by 3ml per week until client reaches  ■
10ml
Continue at 10ml for one month, then ■
Reduction from 10ml to zero may require:  ■
- Buprenorphine or lofexidine detox 
- Continued community detox as above 
- In-patient detox. 
Benzodiazepine detoxifi cation – The aim of 
benzodiazepine detoxifi cation is to become drug 
free, not to be maintained on lower doses. In 
this case, the client shows their commitment by 
attending four care planning meetings over a 
period of two to six weeks. They are also required 
to fi ll out weekly drug diaries1. 
The future – This pilot project will be monitored 
for at least the next 18 months by the steering 
committee. Caroline Gardner is the Progression 
Routes Co-ordinator. progressionroutes@saol.
project.ie 
(Suzi Lyons)
1. See Department of Health and Children (2002) 
Benzodiazepines: good practice guidelines for 
clinicians, pp 21–25. Available on the DOHC 
website at www.dohc.ie/publications. 
Caroline Gardner 
(Progression 
Routes Initiative 
Co-ordinator, SAOL 
Project) speaking at 
the seminar (Photo: JJ 
Berkeley)
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Eurobarometer survey on poverty 
and exclusion
In September 2007, the European Commission 
published a Special Eurobarometer survey of public 
opinion about poverty and exclusion.1 This survey 
canvassed the views of 26,466 respondents in 
the 27 EU member states and 1,000 residents of 
Croatia. TNS MRBI carried out 1,000 interviews in 
Ireland. 
Perceptions about the existence and the causes 
of poverty 
In general, poverty is seen as a widespread problem 
that affects the majority of people to some extent. 
Europeans feel that, in their own area, about three 
people out of ten (29%) live in poverty and one 
person in ten lives in extreme poverty. 
Poverty is seen to affect more people living in new 
member states than in the former EU15 countries 
(63% vs. 32%). However, in the former EU15 
countries there was a signifi cant increase since 
2002 in the proportion of people who perceive 
poverty to exist (+12%).2 
Those surveyed were asked which of four 
statements as to why people live in need was 
closest to their own opinion (Table 1). 
The top three perceived reasons why people are 
poor or excluded from society are work related 
(Figure 1). The fourth reason given is addiction 
(29%). An examination of answers according to the 
respondents’ socio-economic background reveals 
EMCDDA update on GHB/GBL
On 17 March 2008, the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) 
published a thematic paper, GHB and its precursor 
GBL: an emerging trend case study.1 GHB (gamma-
hydroxybutyric acid) is commonly known as liquid 
ecstasy. It was used in the eighties for its body-
building effects, and in the nineties as a recreational 
drug at music venues. In 2000, the EMCDDA 
and its partners carried out a risk assessment on 
GHB and the drug was placed under international 
control by the United Nations in March 2001. Since 
2001 the new controls have curtailed the open sale 
of the drug but there are now concerns over its 
chemical precursors, GBL (gamma-butyrolactone) 
and 1,4-butanediol, which are now being sold 
as substitutes for GHB, and are not controlled by 
international law. 
The chemical precursors of GHB are widely used 
for legitimate purposes (for example, in cleaning 
solvents) and can be purchased over the internet 
from 15 suppliers in Germany, The Netherlands, 
Poland and the UK. Health warnings are displayed 
on 12 of the 15 sites. Italy, Latvia and Sweden have 
introduced controls on one or both precursors. 
GBL and 1,4-butanediol can be used easily to 
manufacture GHB. Indeed, when ingested by 
humans the precursors are naturally converted to 
GHB. 
The use of GHB/GBL in recreational settings is 
relatively uncommon when compared to that of 
ecstasy or cocaine. Little is known about the use of 
these chemicals in private settings. According to 
the authors, the effects of GHB/GBL on humans, 
when taken in small quantities, are similar to those 
of alcohol, but increase greatly with each small 
increase in quantity consumed. The toxic effects 
of the drug include impaired consciousness and 
coma. Hospital emergency departments in Ibiza, 
Amsterdam and London reported a rising number 
of non-fatal overdoses due to GHB or GBL. These 
substances have rarely been shown to be implicated 
in the death of a drug user because forensic analysis 
is diffi cult due to the short period of time it can 
be detected in blood or urine and due to the fact 
that low quantities of GHB are normally present in 
the body. There is little or no evidence to implicate 
GHB in date rape. 
(Jean Long)
1. Hillebrand J, Olszewski D and Sedefov R (2008) 
GHB and its precursor GBL: an emerging trend 
case study. Lisbon: European Monitoring Centre 
for Drugs and Drug Addiction.
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Table 1 Respondents’ opinions as to why people live in need
Europe % Ireland %
Because they have been unlucky 19 26
Because of laziness and lack of willpower 20 16
Because there is much injustice in society 37 30
It’s an inevitable part of progress 13 11
None of these 6 4
Don’t know 5 13
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Figure 1 Perceived reasons* why people are poor or excluded from society 
*Respondents could choose a maximum of three options from those provided. 
Source: Poverty and exclusion Eurobarometer 2007
403020100 50 60
They have been unemployed for a long time
Their current work doesn’t pay enough
Social benefits/pensions are not high enough in our country
They suffer from alcoholism, drug abuse or other addictions
They lack education
They suffer from a long term illness or disability
They have been through a family break-up or lost a family member
They don’t do enough to get by
There is a lack of concern from people around them
They live in a poor area
They suffer from discrimination based on ethnic origin, age, disability or sexual orientation
They cannot access affordable housing
Their parents were poor
They have too many children
Don’t know
Percentage
Europe
Ireland
Figure 2 Perceived reasons* why people become homeless 
*Respondents could choose a maximum of three options from those provided. 
Source: Poverty and exclusion Eurobarometer 2007
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They lose their job or cannot find one
They run into debt
They suffer from addiction (drugs or alcohol)
They go through a family break-up
They have no access to affordable housing
They become ill
They cannot access adequate social benefits
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They lose a close relative
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Eurobarometer (continued)
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a fairly similar ranking. For most groups, the same three 
items top the list, although addiction appears in the top 
three among people living in rural villages (33%), students 
and the youngest respondents (both 32%), managers 
(31%), employees (30%) and those who stayed in full-time 
education until the age of 20 or older (29%). Respondents 
classed by the survey as ‘not poor’ mention addiction more 
frequently (at 36%) than they do some of the work-related 
reasons. Those who believe poverty is a person’s own fault 
are most inclined to see alcoholism and other addictions as a 
reason for poverty (44%). 
Unlike their European counterparts, Irish respondents see 
‘alcoholism, drug abuse or other addictions’ as the most 
likely reason for poverty or social exclusion (49%). 
Causes of homelessness
The Irish also differ from other Europeans regarding 
homelessness. Again, they place higher signifi cance on 
addiction, seeing it as the number one reason for people 
becoming homeless (60% vs. 46% for Europeans) (Figure 2).
All answers were examined in relation to the respondents’ 
own feelings of subjective poverty and degree of fi nancial 
diffi culty. The less economic strain people suffer, the more 
likely they are to see addiction as a cause of homelessness, 
with 56% of people with no economic strain holding this 
view, compared to 33% of people who suffer the most 
economic strain.
Standard of living
The survey fi nished with an examination of what Europeans 
consider acceptable in order to have a decent standard 
of living. Seventy-four items relating to fi nancial means, 
housing conditions, durable goods, basic necessities and 
social integration were included in the survey. Most are 
deemed to be absolutely necessary (31 items) or necessary 
(26 items). There is also a great degree of consensus among 
Europeans regarding the requirements for children to live 
and develop well. 
People’s views about what is required for a decent standard 
of living are most strongly infl uenced by the social norms, 
expectations and values of their country. The actual standard 
of living in a country seems to be less relevant. 
(Mary Dunne)
1. TNS Opinion & Social (2007) Poverty and Exclusion. 
Special Eurobarometer 279. Luxembourg: Offi ce for 
Offi cial Publications of the European Communities. 
http://ec.europa.eu/public_opinion/archives/ebs/
ebs_279.pdf 
2. The 2002 report, Social precarity and social integration: 
Report for the European Commission based on 
Eurobarometer 56.1, was conducted under the 
framework of the Eurobarometer (special Eurobarometer 
162 / Wave EB56.1). It is available at www.ec.europa.eu/
public_opinion/archives/eb_special_en.htm. 
Irish Prison Service annual report 2006
The Irish Prison Service (IPS) annual report for 2006 was 
published in December 2007.1 In 2006 there were 12,157 
committals to prison: 5,642 under sentence; 5,311 on 
remand; 1,196 under immigration law; and eight for 
contempt of court. These committals related to 9,700 
individuals. Of the 5,642 sentenced committals, 113 were 
for intoxication (by alcohol) in a public place and 395 for 
drug offences (up 29% on the 2005 fi gure). 
The IPS aims ‘to provide a range of care services to prisoners 
to a standard commensurate with that obtaining in the 
wider community’. Included are medical, dental, psychiatric, 
psychological, education, vocational training, work, welfare, 
spiritual, counselling and recreational services. Healthcare is 
provided to prisoners by psychiatrists, general practitioners, 
nurses, counsellors and medical orderlies.
Drugs and prison
In May 2006 the Minister for Justice launched the IPS drugs 
policy and strategy document, Keeping drugs out of prisons. 
This sets out the steps required to tackle the supply of drugs 
into prisons, to provide adequate treatment services to those 
who are addicted to drugs, and to ensure that developments 
in the prisons are linked to those in the community. The 
IPS has reported signifi cant progress in implementing this 
strategy. 
Treatment and rehabilitation services
New services and programmes for addicted prisoners were 
developed in 2006. These were delivered by the IPS in 
partnership with the Health Service Executive (HSE) and 
contracted private services. 
Seven nurse offi cers and fi ve prison offi cers were • 
allocated to dedicated drug treatment teams in 
Cloverhill and Wheatfi eld prisons. 
An additional consultant in addiction was provided • 
to improve the quality and co-ordination of drug 
treatment in prisons. 
A contract was awarded to Merchants Quay • 
Ireland to provide access for prisoners to addiction 
counselling (1,000 hours per week). 
The Dormant Accounts Fund fi nanced four • 
community groups to provide addiction counselling 
and other supports to prisoners while in prison and 
on release in the community. 
A consultant-led infectious diseases service was • 
contracted from St James’s Hospital to provide 
treatment to prisoners who suffer from infectious 
diseases. It is hoped to expand this service to 
other sites. 
A HSE consultant in forensic psychiatry in the • 
Western Region was contracted to provide dedicated 
sessions to Limerick Prison.
The second contracted pharmacy service was • 
introduced to Loughan House (an open prison) in 
April 2006.
A tender for dedicated pharmacy services to • 
provide drug treatment was developed and awarded. 
This will provide pharmacy services in a number of 
closed prisons. 
Eurobarometer (continued)
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IPS annual report (continued)
The psychology service in Irish prisons increased • 
its team to seven clinical psychologists, eight 
counselling psychologists and one forensic 
psychologist.
Further work was undertaken to promote and • 
facilitate the use of the prison medical record system 
through training and support, and the development 
of changes based on user feedback.
Nine prisons provided methadone treatment to 1,579 
prisoners in 2006, of whom 162 were receiving methadone 
for the fi rst time (Table 1). It is noteworthy that methadone 
treatment was not provided in two large prisons, Cork 
and Castlerea. 
Eliminating the supply of drugs 
During 2006 the IPS intensifi ed its focus on preventing illicit 
drugs being brought into prisons. The traditional means of 
effecting supply reduction – staff vigilance, physical searches 
and supervision of people entering prisons – continue to be 
reinforced by means of improved facilities and procedures. 
Specifi c measures put in place in 2006 include:
More secure prisoner visiting arrangements, which • 
involve greater control over the number and identity 
of visitors, and enhanced supervision of such visits 
Enhanced perimeter security through improved • 
netting and closer co-operation with the Garda 
Síochána
Enhanced technology for searching of cells and • 
prison property, resulting in improved detection and 
seizure of contraband
The introduction of dogs to detect drugs on people • 
entering prisons and to aid searches within prisons. 
(Vivion McGuire and Jean Long) 
1. Irish Prison Service (2008) Annual report 2006. Dublin: 
Irish Prison Service.
Drug tests in Irish prisons
Information on drug testing in prisons from 2005 to 2007 
was obtained from the Irish Prison Service by The Irish Times 
under the Freedom of Information Act.1,2,3 According to this 
data, more than 20,000 voluntary tests were carried out 
each year to monitor drug use and responses to treatment. 
These tests included those carried out on committals (new 
entries) as well as on existing inmates. It may be assumed 
therefore that some of the positive test results relate to drugs 
or alcohol consumed outside the prison. Between one-third 
and one-half of those screened tested positive for at least 
one drug. The common metabolites detected indicated use 
of cannabis, benzodiazepines and opiates (Table 1). It is 
not clear whether the numbers of positive cases excluded 
prisoners who were prescribed benzodiazepines; if they do 
not, these fi gures overstate the extent of unregulated use 
of benzodiazepine in prisons. Cocaine and alcohol were 
detected in a small number of tests. The profi le of positive 
drug tests was similar among prisoners tested in Mountjoy, 
Wheatfi eld, Limerick, Midland and Cloverhill prisons. The 
proportion of positive tests was low in St Patrick’s Institution 
and in Castlerea and Cork prisons. 
(Jean Long) 
1. Conor Lally (18 February 2008) 40,000 positive drug 
tests in prisons. Irish Times: 1.
2. Conor Lally (18 February 2008) Prison drugs fi gures 
show extent of challenge ahead. Irish Times: 4.
3. Data confi rmed in personal communication with W 
Burke of the Irish Prison Service (13 June 2008). 
Table 1 Numbers of individuals receiving methadone treatment* in Irish prisons in 2006
Prisons Total patients 
during 2006
New patients in 2006 Number on 31 
December 2006
Cloverhill Prison 678 107 175
Dochas Centre 216 20 32
Limerick Prison 8 0 6
Midlands Prison 19 2 12
Mountjoy Main Prison 416 13 145
Mountjoy Prison Medical Unit 48 2 12
Portlaoise Prison 2 1 2
St Patrick’s Institution 8 1 6
Wheatfi eld Prison 184 16 82
Total 1579 162 472
*Methadone treatment in this context is either substitution or detoxifi cation.
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The Local/Regional Task Force Community Representatives 
Conference, facilitated by CityWide and hosted by the 
National Drugs Strategy Team (NDST) and the Inter-
Departmental Group on the National Drugs Strategy (IDG), 
took place at the Killeshin Hotel in Portlaoise from 4 to 6 
April. In light of the development of the new National Drugs 
Strategy 2009–2016, the main objective of this conference 
was to consult with community representatives so as to 
identify priority actions needed to address drug misuse in 
communities. A further objective included establishing how 
communities can play a lead role in developing, planning 
and delivering the new National Drugs Strategy. 
The conference commenced with opening addresses from 
Garda Detective Superintendent Barry O’Brien, Chairperson 
of the National Drugs Strategy Team; Anna Quigley, Co-
ordinator of CityWide Drugs Crisis Campaign and Pat Carey 
TD, the then Minister of State with responsibility for drugs 
strategy. The Minister acknowledged the progress made 
since 1996, but underlined the need for advances in the area 
of rehabilitation. He was particularly eager to establish the 
National Drug Rehabilitation Implementation Committee. In 
relation to the new strategy, he urged communities to voice 
their concerns and ideas: ‘The development of this new 
strategy gives all of you an opportunity to voice your views 
and I believe that “everything is up for grabs” in relation to 
developing a new strategy.’
While the three key areas focused upon were drug 
treatment, supply control and prevention, a recurring theme 
throughout the conference was the perceived need for a 
revised set of political structures to deal with drug misuse. 
Fergus McCabe, community representative for the IDG, 
argued that drug misuse requires a special ministry and 
a cabinet committee located in either the Department of 
Health or the Department of the Taoiseach. 
Drug treatment and prevention
Liam O’Brien of CARP, Tallaght, outlined the development 
of drug treatment in Ireland since the early 1990s. He noted 
that some of the biggest challenges in the current climate 
include the emergence of cocaine as a destabilising infl uence 
on recovering opiate users, the reluctance to acknowledge 
the damaging effects of alcohol abuse and the unwillingness 
of communities outside Dublin to acknowledge growing 
opiate misuse in their areas. 
The drug treatment workshop produced a set of priority 
actions which included:
Implement the NACD recommendations on drug use • 
and mental health.
Identify gaps in service provision. • 
Review the effectiveness of existing treatment • 
options.
Meet women’s needs, especially in relation to • 
childcare.
With regard to prevention, Martin Hayes, community 
representative on the NDST, highlighted the need for 
fresh thinking in prevention strategies. He suggested that 
harm reduction can be seen as a preventative strategy as it 
prevents an escalation in serious drug-related harms. Priority 
actions from the prevention workshop included:
Audit the Social, Personal and Health Education • 
(SPHE) and Walk Tall programmes to ascertain if and 
how schools are delivering them.
Task force community representatives 
conference
Table 1   Numbers of tests, by prison, and number (%) of positive tests, by prison and by drug type, 2007 
Prison No. of 
tests
Cannabis Benzodiazepines Opiates Cocaine Alcohol Amphetamines
Mountjoy Main 3,680 1,860 (51%) 1,871 (51%) 2,112 (57%) 78 (2%) 23 (0.6%) 29 (0.8%)
Dochas Centre 2,464 844 (34%) 1,294 (50%) 751 (46%) 85 (11%) 55 (3%) 14 (1%)
Wheatfi eld 4,369 2,122 (49%) 1,572 (36%) 1,842 (44%) 51 (1%) 31 (0.7%) 35 (0.8%)
Cloverhill 3,301 833 (25%) 1,206 (37%) 1,141 (35%) 267 (8%) 79 (2%) 31 (0.9%)
St Patrick’s Instit. 3,489 245 (7%) 179 (5%) 86 (3%) 12 (0.3%) 14 (0.4%) 20 (0.6%)
Castlerea 92 14 (15%) 17 (19%) 9 (10%) 0 (0%) 0 (0%) 2 (2%)
Loughan House 407 128 (32%) 55 (14%) 16 (4%) 7 (2%) 9 (2%) 8 (2%)
Shelton Abbey 382 97 (25%) 45 (12%) 22 (6%) 19 (5%) 12 (3%) 10 (3%)
Limerick 518 189 (37%) 233 (43%) 228 (44%) 3 (0.6%) 18 (4%) 5 (1%)
Cork 97 3 (3%) 8 (8%) 1 (1%) 0 (0%) 1 (1%) 0 (0%)
Midland 1,694 263 (16%) 422 (25%) 871 (51%) 18 (1%) 9 (0.5%) 9 (0.5%)
Portlaoise 20 3 (15%) 4 (20%) 4 (20%) 0 (0%) 1 (5%) 0 (0%)
Source: Data received from the Irish Prison Service 
Drug tests in Irish prisons (continued)
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Include a community representative on the SPHE • 
programme.
Develop culturally sensitive programmes and • 
collaborate with leaders of new communities in 
Ireland.
Implement best practice to support parents and • 
families.
Supply control
Criminologist Johnny Connolly of the Health Research Board 
highlighted the signifi cant gaps in our understanding of how 
illicit drug markets operate. He pointed out that, despite the 
major anxiety within society about drug-related crime and 
the huge resources invested in drug law enforcement, we 
have very limited information on how these resources are 
used or what sort of impact they have. He suggested that 
there is growing evidence internationally that partnership 
between stakeholders including local communities, law 
enforcement, local authorities and health workers offers 
the most sustainable method of responding to many drug 
problems in this area. He suggested that the joint policing 
committees and, in particular, the local policing fora being 
rolled out in line with the National Drugs Strategy and the 
Garda Síochána Act, 2005, have the potential to provide 
the necessary infrastructure through which such partnership 
approaches can be delivered at local level. 
Priority actions from the supply control workshop 
included:
Put community policing fora in place in all LDTF • 
areas as a matter of urgency and facilitate discussion 
as to how the model can be adapted to RDTF areas.
Develop a more intensive and targeted response to • 
drug ‘hotspots’ identifi ed at local level.
Implement a national programme of arrest referral • 
schemes.
Encourage liaison between the Courts Service, the • 
NDST and drugs task forces to progress Action 72 of 
the strategy relating to the training of members of 
the judiciary.
Expand the means by which people can safely and • 
anonymously contact the gardaí in relation to drug 
dealing.
Ring-fence money obtained through the Criminal • 
Assets Bureau for re-investment in local communities 
most affected by drugs.
Address drug supply within the Traveller community • 
in local and regional policing plans.
Sinead Smyth of Pavee Point emphasised the importance 
of accommodating the needs of communities of interest1 
in the next drugs strategy. She reported that groups such 
as Travellers and immigrants are often under-represented in 
service delivery and emphasised that ‘there needs to be a big 
push within the NDS to support equality issues as it is very 
ad hoc and piecemeal’. 
Dr Gemma Cox of the National Advisory Committee on 
Drugs (NACD) emphasised the importance of developing 
an integrated set of measures or community indicators to 
aid targeted action and help relevant bodies monitor the 
benefi ts to the community of actions around drugs.2 Dr 
Mary Ellen McCann of University College Dublin (UCD) 
presented results from a collaborative study by CityWide, 
UCD and the NDST which assessed the role and experience 
of community representatives. There are 140 representatives 
nationally who are generally nominated, invited or elected 
to their position. The study reported that the role of 
community representatives mainly involved taking issues 
form the grassroots level and feeding them into task forces, 
assisting in emergencies and planning.  The study also 
found that, while community representatives appreciate 
the opportunity to contribute to the development of 
their communities, many were dissatisfi ed with the minor 
impact they felt they were currently making. A report on 
the conference will be provided by CityWide Drugs Crisis 
Campaign in the coming weeks and can be accessed on 
their website www.citywide.ie. 
(Anne Marie Donovan and Johnny Connolly) 
1. Communities of interest have been described as groups 
or communities who have shared identity, experiences 
and purposes. They are often referred to as ‘hard to 
reach groups’.
2. More details on community indicators are reported 
in Loughran and McCann (2006) A community drugs 
study: developing community indicators for problem 
drug use. Dublin: NACD.
Task force conference (continued)
Copies of Spring issue of Hyper available 
from NDC: 01 2345175 or ndc@hrb.ie
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Between 10 and 14 March 2008 the Commission on 
Narcotic Drugs (CND), the central policy-making body of 
the United Nations (UN) in drug-related matters, met in 
Vienna for its 51st Session.1 A key event at the Session was 
a thematic debate on progress achieved by governments in 
meeting the goals and targets for the years 2003 and 2008 
as set out in the Political Declaration adopted by the UN 
General Assembly Special Session (UNGASS) on Illicit Drugs 
in 1998.2 Broadly speaking, the goals and targets included 
achieving signifi cant and measurable results in the fi eld of 
demand reduction; eliminating or signifi cantly reducing the 
illicit manufacture, marketing and traffi cking of psychotropic 
substances; and eliminating or signifi cantly reducing the 
illicit cultivation of the coca bush, the cannabis plant and the 
opium poppy. 
The following is a summary of the ‘salient points’ made in 
this debate, as identifi ed by the Chair of the Commission:
General comments
In the 10 years since the adoption of the Political  ■
Declaration, progress had been made; for example, 
today there is a more structured legal scheme and better 
tools for the international fi ght against drugs. 
However, the objectives established in 1998 have not 
been accomplished.
The quality of the information on which the performance  ■
of the international drugs control scheme is assessed 
needs to be improved.
The importance of the principle of common and shared  ■
responsibility, as enshrined in Article 2 of the Political 
Declaration, was a recurrent theme in the debate. 
Speakers reminded participants that at the centre of the 
international fi ght against drugs are human beings.
Demand reduction
An evidence-based and long-term sustained  ■
comprehensive approach to demand reduction is 
necessary. This approach should take into consideration 
the imbalance of resources for demand reduction; the 
stigma on drug dependent persons; and the need to 
focus on the reduction of human suffering, including 
measures to reduce the harm caused by drugs, as one 
of the main aims of the international drug control 
conventions.
Civil society and the capacity of non-governmental  ■
organisations (NGOs) need to be engaged in efforts to 
reduce the demand for drugs.
Supply reduction
As regards the fi ght against illicit drug supply, the  ■
thematic debate recognised the progress made on 
many fronts including the development of national drug 
strategies, improved enforcement capacities and regional 
and international co-operation.
At the same time, the debate confi rmed that there have  ■
been signifi cant changes over the past 10 years in illicit 
drug supply, including:
new traffi cking trends• 
diversifi ed sources of production of drugs, including • 
the illicit manufacture and trade of ATS
the increasing use of alternative or substitute • 
chemicals that are not subject to international or 
national control
the impact of globalisation in reducing the difference • 
between producer and consumer countries in the 
production, traffi cking and consumption of drugs
the ever-growing links between drug traffi cking and • 
international organised crime.
UN assesses progress in tackling world 
drug problem 
On 3 April 2008, Merchants Quay Ireland (MQI) launched 
the booklet Safer injecting at a seminar focused on reducing 
the harm associated with injecting drug use.1 
In launching the guide, Minister of State Pat Carey TD 
stated that the reality of substance misuse meant that, in the 
short term, abstinence was rarely achievable, making harm 
reduction interventions necessary. He said that there was a 
need to develop more needle and syringe-exchange services 
in Ireland, while acknowledging that such action might 
invite criticism. 
This safer injecting guide is produced for people who inject 
drugs. The booklet includes advice about safer injecting 
practices and different types of injecting – into a vein or 
muscle, or under the skin (skin popping). The importance 
of washing one’s hands prior to injecting to reduce the risk 
of infection is a simple and important point highlighted in 
the guide. Advice is provided about how to look after veins 
and decrease vein damage. Readers are encouraged to seek 
medical attention if they experience any health-related 
issues associated with injecting. A full description of the 
necessary injecting equipment is provided, along with the 
important statement that ‘single-use syringes are the safest 
as water and/or bleach will not destroy all viruses’. Overdose 
prevention techniques and responses are described, along 
with information on the increased risk of overdose due 
to polydrug use. The necessity for protection against the 
acquisition and transmission of blood-borne viruses is also 
discussed. 
For further information, contact Merchants Quay Ireland on 
(01) 645 6524/00 or www.mqi.ie, or drop in to the service 
at 4 Merchants Quay, Dublin 8.
(Janet Robinson)
1. Merchants Quay Ireland (2008) Safer Injecting: reducing 
the harm associated with injecting drug use. Dublin: MQI.
MQI safer injecting guide
25
drugnet 
IRELAND
As well as the thematic debate, and deliberations on the 
reports tabled by UNODC and the INCB, the Session also 
passed 18 resolutions. Among these were the following: 
Cannabis
Refocusing prevention, education and treatment efforts  ■
for young people 
Reducing the demand for and abuse of cannabis ■
Combating the illicit cultivation of and traffi cking in  ■
cannabis
Drug users
Promoting early detection of drug use cases by health  ■
and social care providers by applying the principles of 
interview screening and brief intervention approaches to 
interrupt drug use progression and, when appropriate, 
linking people to treatment for substances abuse
Strengthening co-operation between the UN Offi ce  ■
on Drugs and Crime and other UN bodies for the 
promotion of human rights in the implementation of the 
international drug control treaties
Promoting co-ordination and alignment of decisions  ■
between the Commission on Narcotic Drugs and 
the Programme Coordinating Board of the Joint UN 
Programme on HIV/AIDS
Drug control
Strengthening cross-border co-operation in the area of  ■
drug control
Achieving a balance between demand for and supply of  ■
opiates used to meet medical and scientifi c needs 
Strengthening international co-operation for the control  ■
of precursor chemicals used for the manufacture of 
synthetic drugs
Responding to the threat posed by the distribution of  ■
internationally controlled drugs on the unregulated 
market
Controlling international movement of poppy seeds  ■
obtained from illicitly grown opium poppy plants 
Sharing information on the use of non-scheduled  ■
substances as substitutes for scheduled substances 
frequently used in the illicit manufacture of narcotic 
drugs and psychotropic substances, and on new 
methods of manufacture of illicit drugs.
(Brigid Pike)
1. The CND Report on the Fifty-fi rst Session (Advanced 
unedited version, E/2008/28; E/CN.7/2008/15) is 
available at www.unodc.org/unodc/en/commissions/
CND/session/51.html. The report sets out in full the 
18 resolutions passed by the CND; summarises the 
deliberations on the thematic debate together with 
the Chair’s summary; and provides an account of the 
deliberations on drug demand reduction, illicit drug 
traffi c and supply, and the implementation of the 
international drug control treaties. The reports that 
informed this last series of deliberations are also available 
on the UNODC website.
2. The Political Declaration is available at www.un.org/
ga/20special/poldecla.html. 
Online innovation and use of new 
technologies 
In April the Drug and Alcohol Programme (DAP) launched a 
new section of the www.drugs.ie website. This new section 
provides a discussion forum for professionals working in the 
area of drug and alcohol addiction. 
So far 125 professionals in the fi elds of drug prevention and 
education, research and treatment have registered to use 
the forum. A core group of regular contributors has begun 
discussions on a wide variety of topics including concepts 
of best practice, the National Drugs Awareness Campaign 
and early-warning systems. These online discussions provide 
an opportunity for professionals in the drugs fi eld to share 
knowledge in an informal and constructive environment. 
The forum also harnesses the benefi ts of an online 
environment, the ability to work and communicate across 
geographic boundaries and the power to link directly to 
relevant resources. 
The forum is structured under the following headings:
General Drugs Discussion  ■
UN and the world drug problem (continued)
drugs.ie websitedrugs.ie website
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Research & Development Discussion  ■
(A forum for discussion on topics relating to research and 
development in the drugs fi eld in Ireland)
National Drugs Strategy Discussion  ■
(A forum specifi cally for discussion on the Irish National 
Drugs Strategy) 
Resources ■
Upcoming Events ■
Training  ■
Jobs ■
This forum is the fi rst of its kind in the drugs fi eld in Ireland. 
If you would like to register to use the forum, send an 
email to helpline@dap.ie. Please include your full name, 
organisation, email address and telephone number. Staff 
from the drugs.ie site will then contact you to complete your 
registration.
Social networking sites
Other drug-related organisations are developing an 
internet presence. Prevention and youth groups have been 
developing a presence on the popular social networking 
sites. The Southern Regional Drugs Task Force has 
maintained a presence on the popular Bebo site since 2007 
and it can be accessed at www.bebo.com/drugstaskforce. 
The site provides links to the recent national drug awareness 
campaign ‘The Party’s Over’ and to the current HSE 
underage drinking campaign video. 
The Fermoy Community Drugs Initiative Bebo site (www.
bebo.com/MartinaM58) was created in February 2008 
and is maintained by Martina Munnelly, a community 
drugs outreach worker. The Fermoy site includes links to 
Cork-based youth cafés, news cuttings on the dangers of 
binge drinking and embedded videos of innovative drug 
prevention campaigns from Australia on the dangers of 
cannabis use. 
The power of such social networking sites lies in their 
ability to create and foster online networks or groups of 
people with similar interests. Young people are encouraged 
to ‘become friends’ and join a network with groups such 
as the Fermoy Community Drugs Initiative or the Bantry 
Youth Café, which has 362 friends. Visitors can upload 
photographs, leave comments, add drug awareness 
campaigns to their site and create a journal or blog of 
activity. 
At the international level, America’s Truth campaign, 
designed to prevent young people from smoking, has 
established a strong presence on multiple social networking 
sites including Bebo (16,077 friends), Xanga and My Space. 
Customised search engines
A recent innovative development is the Addiction Search 
Engine (www.addictionsearch.net). Tony Duffi n, director 
of the Ana Liffey Drug Project, has used the Google search 
engine to create a customised search engine which searches 
over 600 dedicated drugs and drug-related websites. The 
selected sites include the National Documentation Centre 
on Drug Use, EMCDDA, NACD, Drug Policy Action Group, 
Merchants Quay Ireland and a large number of quality 
international drug-related sites. By using the Addiction 
Search Engine as a fi rst port of call when performing an 
internet search, you will fi nd many more signifi cant and 
useful results than you would by doing a general Google 
search. It is certainly a page to be added to ‘my favourites.’ 
The use of online forums, social networking websites and 
customised search engines by drug awareness campaigns, 
task forces and prevention groups is a relatively new 
phenomenon in Ireland. Many of these sites are built on 
openly accessible software or ready-made platforms such 
as My Space or Google Custom Search. As such, the cost 
involved in developing such an online presence is often low, 
but it takes commitment and time to investigate, develop 
and maintain the sites. Often this work is undertaken 
voluntarily. The use of these innovative technologies 
demonstrates a desire among Irish drugs workers to share 
knowledge and to provide accurate and timely drug-related 
information in a variety of accessible formats.
(Louise Farragher)
drugs.ie website
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Departing ADRU Staff 
Siobhán Reynolds
At the end of January 2008, Siobhán Reynolds left the 
Alcohol and Drug Research Unit (ADRU) where she had 
worked as an analyst with the National Drug Treatment 
Reporting System since January 2005. During this time 
Siobhán made a signifi cant contribution to the NDTRS. 
Siobhán will be missed by her colleagues in the ADRU and 
by those outside the HRB with whom she worked in data 
co-ordination. We wish her every happiness and success in 
her new position.
 
Lorraine Coleman
At the end of February 2008, Lorraine Coleman left the 
Alcohol and Drug Research Unit (ADRU) where she had 
worked as a researcher with the National Drug-Related 
Deaths Index since August 2005. During this time Lorraine, 
alongside her colleagues, collected seven years’ data on 
drug-related deaths from the coroners’ services. Lorraine 
will be missed by her colleagues in the ADRU and Coroner 
Services. We wish her every happiness and success in her 
new position.
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In brief
In 2008 the Democracy, Cities and Drugs (DC&D) 
II project 2008-2010 was launched. Based on the 
lessons learned from the fi rst DC&D project, DC&D 
II aims to help EU cities develop local, partnership-
based drug policies and practices involving all 
relevant stakeholders. www.democitydrug.org 
During 2008 the Children Acts Advisory Board 
(CAAB), whose mission is to seek signifi cantly 
better outcomes for vulnerable children through 
the co-ordinated delivery of services, has been 
upgrading its website. www.caab.ie 
On 24–29 January 2008 as part of Beyond 2008 
– A global forum on the 1998–2008 review of 
the United Nations General Assembly Special 
Session on Illicit Drugs, the regional consultation 
for the European Union and EFTA countries was 
held in Budapest. The report from this consultation 
is available on the website of the Vienna NGO 
Committee on Narcotic Drugs. www.vngoc.org 
On 5 February 2008 COSC, the National Offi ce for 
the Prevention of Domestic, Sexual and Gender-
based Violence, launched its website. Set up in 
June 2007, Cosc (which means to stop or prevent) 
works with other organisations in the sector to 
ensure the delivery of co-ordinated services for 
victims, raises awareness about the level and impact 
of these crimes and about local services for victims, 
and develops strategies for preventing and dealing 
with these crimes in line with best international 
practice and standards for service delivery and for 
training programmes. www.cosc.ie 
On 5–7 March 2008 the World Red Cross/Red 
Crescent (RC/RC) Congress on Humanitarian 
Drug Policy was held in Barcelona. After the 
conference, the attending youth staff and 
volunteers held an additional youth meeting 
with representatives of 11 national societies, the 
International Federation and the Senlis Council, 
the think-tank that had sponsored the event. 
At this meeting, participants discussed current 
programmes and new ideas related to working with 
drug users. www.ifrc.org / www.senliscouncil.org 
On 12 March 2008 Stereotyping of young 
people, a resource pack developed by the Equality 
Authority and the National Youth Council of 
Ireland, was launched. It is intended to support 
young people and youth organisations to recognise 
and challenge stereotyping of young people. www.
equality.ie / www.nyci.ie 
On 12 March 2008 What research tells us about 
the reasonableness of the current priorities of 
national drug control was presented by Rosalie 
Pacula of the RAND Drug Policy Research Center 
before the US House Oversight and Government 
Reform Committee, Subcommittee on Domestic 
Policy. In her testimony Pacula argued:
although the US drugs strategy appears 1. 
‘balanced’, being based on three primary 
objectives – to stop use before it starts, to heal 
America’s drug users, and to disrupt illicit drug 
markets – the budget refl ects a strong emphasis 
on supply reduction efforts (65.2% of the 
requested  budget for 2009); 
the problem with this unbalanced approach 2. 
becomes clear if you understand the epidemic 
nature of drug problems and the current stage 
of the expected epidemic for each major drug 
of abuse in the US today. The current mix 
of enforcement, prevention and treatment 
strategies is not the optimal for managing the 
drug situation the US faces; and
the problem is not just one of balance in the 3. 
budget, but also one of waste. In several areas, 
the 2008 National Drug Control Strategy 
advocates continuing or new support for 
programmes that have either (a) never been 
scientifi cally proven to be effective and which 
on analytic grounds seem unlikely to be 
successful or (b) have already been shown to 
be completely ineffective. www.rand.org/multi/
dprc/ 
On 27 March 2008 the National Youth Justice 
Strategy 2008–2010 was launched. The Strategy 
focuses on children who have already had some 
contact with the criminal justice system. Under 
the objective ‘To make the youth justice system 
more effective through providing clear, unifi ed 
and strategic leadership’, the Department of 
Community, Rural and Gaeltacht Affairs is called 
on to: ‘Work with the Irish Youth Justice Service 
(IYJS) to ensure that appropriate synergies are 
achieved between the National Youth Justice 
Strategy and policies and the aims of the National 
Drugs Strategy 2001–2008 and its successor, RAPID 
and CLÁR programmes, and community and local 
development programmes, and that there is a 
coordinated approach to the delivery of services to 
disadvantaged areas’. www.iyjs.ie 
In March 2008 the Beckley Foundation Drug 
Policy Programme published its 13th report 
Recalibrating the regime: the need for UN system-
wide coherence in drug control and human rights. 
The report looks at the tensions between some 
aspects of the global drug control system, and UN 
human rights standards. www.beckleyfoundation.
org/policy 
On 21 April 2008 Barnardos launched a new family 
support initiative. Barnardos’ project in Buckingham 
Street, in Dublin’s north inner city, will work with 
children from birth to about the age of 12 who 
face severe or chronic threats to their well-being 
– for example, children who come from families 
where there is addiction, fi nancial pressure, parents 
in prison, or a parent with mental illness. www.
barnardos.ie 
On 23 April 2008 the Central Statistics Offi ce 
(CSO) released Garda recorded crime statistics 
2003–2006, the fi rst set of crime statistics using the 
newly completed Irish Crime Classifi cation System 
(ICCS), which replaces the headline/non-headline 
offence classifi cation introduced in 2000. Drug-
related offences form a distinct class of offences in 
the new system. www.cso.ie 
(Compiled by Brigid Pike)
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From Drugnet Europe 
Estimating the total burden of drug-related mortality
Cited from article by Danica Klempová and Julián Vicente in 
Drugnet Europe No. 62, April–June 2008 
The EMCDDA’s key indicator on drug-related deaths collects 
information predominantly on drug-induced deaths (also 
described as poisonings or fatal overdoses). Several causes of 
death, besides fatal overdose, are found to be considerably 
higher in problem drug users than among their peers. These 
include diseases (e.g. HIV/AIDS, liver disease); trauma (e.g. 
accidents, homicide) and suicide. It was estimated that in 
the 1990s and early 2000s, 10–20 % of mortality among 
young adults in several European cities studied could be 
attributed, directly or indirectly, to opioid use.
Two innovative approaches, applied to date in only a few 
studies, involve estimating the total burden of mortality 
related to drugs by:
applying the information from cohort studies to • 
national estimates of the prevalence of problem drug 
use; or 
estimating drug-attributable fractions and applying • 
them to general mortality registries.
Using these methods, the EMCDDA launched a project 
with Czech experts in 2007 to analyse data availability and 
the methodological possibilities for estimating the overall 
mortality of problem drug users in the EU. The project, 
running until the end of the year, will culminate in a report 
that will provide the basis for possible work on this issue at 
EU level in the future.
EMCDDA launches best practice portal
Cited from article by Jennifer Hillebrand in Drugnet Europe No. 
62, April–June 2008
The EMCDDA has launched the fi rst version of its 
Internet portal on best practice in the fi elds of drug-
related prevention, treatment, harm reduction and social 
reintegration. The portal project was conceived to meet 
the needs of professionals, policy-makers and researchers. It 
offers an array of tools and standards designed to improve 
the quality of interventions and highlight examples of 
evaluated practice across Europe. Also available are links to 
further information sources and a glossary to help guide the 
user through the portal. 
The portal is divided into four sections: evidence of effi cacy; 
tools for evaluating practices; standards and guidelines for 
the implementation of practices; and examples of evaluated 
practices (Exchange on Drug Demand Reduction Action – 
EDDRA). 
Evidence of how interventions work in real-life conditions 
can be found in the new edition of the EDDRA databank, 
now available through the portal. EDDRA is primarily 
designed to help professionals and policy-makers plan and 
implement interventions in response to drugs. The databank 
features examples of evaluated interventions in different 
countries and settings, thus helping to generate evidence of 
effi cacy of demand reduction projects. 
Visit the EMCDDA best practice portal at www.emcdda.
europa.eu/themes/best-practice
Drugs in focus – policy brieﬁ ng
No. 18: Substance use among older adults: a neglected 
problem
According to this briefi ng in the EMCDDA Drugs in focus 
series, the number of older people with substance use 
problems or requiring treatment for a substance use disorder 
is estimated to more than double between 2001 and 2020, 
placing new and greater demands on treatment services.  
Programmes that are accustomed to dealing mainly with 
young populations will need to adapt to meet the needs of 
this older group.
The paper discusses key issues in relation to substance use 
in older people under six headings: prescribed and over-
the-counter drugs; illicit drugs; alcohol; special risks for 
the elderly; identifi cation and assessment; and treatment 
interventions and services. 
The briefi ng concludes with a series of policy considerations:
Relatively little is known about the treatment of  ■
substance use in older adults. However, older patients 
engage well with treatment programmes, and can 
achieve satisfactory treatment outcomes. 
Problematic use of prescribed and over-the-counter  ■
medications by older adults is common. Improved 
identifi cation requires regular monitoring of medication 
use and treatment response, and careful assessment of 
other social and health problems that could be caused 
by substance use.
The prevalence of illicit drug use by older adults is  ■
increasing. Addiction treatment and other healthcare 
services are insuffi ciently aware of the needs of older 
drug users and need to anticipate and prepare for 
predicted increases in demand from this age group.
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Recent publications
Journal articles
The following abstracts are cited from recently published 
articles relating to the drugs situation in Ireland.
Methadone induced torsade de pointes in a patient 
receiving antiretroviral therapy
Falconer M and Molloy D 
Irish Medical Journal 2007; 100(10): 631–632
Adverse drug reactions account for approximately 5% 
of acute medical admissions. A 34-year-old male patient 
receiving antiretroviral therapy, methadone and fl urazepam 
presented to the emergency room following collapse 
with associated loss of consciousness. Cardiac monitoring 
demonstrated marked Q-T prolongation followed by the 
cardiac arrhythmia, torsade de pointes. The patient made 
a full recovery following withdrawal of the antiretroviral 
therapy and a reduction in methadone dose. Methadone is a 
recognised cause of this potentially fatal cardiac arrhythmia 
which is more likely to occur when methadone metabolism 
is inhibited by drugs such as HIV tease inhibitors.
Rabbitte revisited: the fi rst report of the ministerial task 
force on measures to reduce the demand for drugs - ten 
years on
Butler S 
Administration 2007; 55(3): 124–144
In this article, Shane Butler revisits the First Report of the 
Ministerial Task Force on Measures to Reduce the Demand 
for Drugs better known as the ‘Rabbitte report’ to examine 
how the report has infl uenced Irish drugs policy since its 
publication in 1996.  He concludes that the Rabbitte report 
introduced a more ‘normalised’ and routine style of drug 
policy making in Ireland and that the statutory structures put 
in place as a result of the report, including the Local Drugs 
Task Forces, continue to operate as part of the national 
response to the drugs situation. 
Treatment response of bipolar and unipolar alcoholics to 
an inpatient dual diagnosis programme
Farren CK and Mc Elroy S 
Journal of Affective Disorders 2007; 106(3): 265–272
Depressed and bipolar alcoholics represent a signifi cant 
affective subgroup that has a poorer prognosis than 
either diagnosis alone. To date few systematic treatment 
programs have been developed to treat dual diagnosis. An 
inpatient treatment program was developed at St Patrick’s 
Hospital Dublin to treat dual diagnosis clients with alcohol 
dependence and either unipolar or bipolar affective disorder. 
Clients (N=232) were assessed for depression, anxiety, 
elation, cravings, drink and drug intake on admission, 
discharge, 3 and 6 months post-discharge from the 
programme. 
In the overall group there was a reduction in number of 
drinking days and units per drinking day over the study 
(p<.01). There was a 71.8% complete abstinent rate at 3 
months and 55.8% at 6 months in the depression group, 
non-signifi cantly greater than for the bipolar group at 64.7% 
and 54.1% respectively. Gamma GT, MCV and craving 
scores were signifi cantly reduced over time (p<.01). Mania, 
depression and anxiety inventory scores fell over time in 
both groups (p<.01). 15-21year-olds were more severely 
anxious, had higher illicit drug use, and were more likely to 
relapse to drug use than older clients. Bipolar 1 clients were 
signifi cantly more likely than bipolar 2 clients to be on mood 
stabilisers at all follow-up stages (p<.001). The authors stated 
that the research was limited by the fact that no control 
group was used.
The authors concluded that there is evidence for effi cacy of 
a specifi cally designed dual diagnosis inpatient treatment 
program as both depressed and bipolar alcoholics had 
signifi cant reductions in all measurements of mood, craving, 
and alcohol/drug consumption by self report and biological 
markers, suggesting both diagnoses can be effectively 
treated together.
Recipient syringe sharing and its relationship to social 
proximity, perception of risk and preparedness to share
Smyth BP and Roche A 
Addictive Behaviors 2007; 32(9): 1943–1948
The authors examined the association between the perceived 
risk attached to recipient syringe sharing and the past and 
future practice of this unsafe injecting activity. Injecting drug 
users (IDU) with a history of past sharing with sexual partner 
identifi ed signifi cantly less risk in this activity compared to 
those with no past history of borrowing from sexual partner. 
Signifi cant differences in risk perception were also found 
when comparing IDU with and without a history of sharing 
with close friends and with acquaintances. Preparedness to 
share in the future was signifi cantly associated with lower 
perceived risk in borrowing from sexual partners (p=0.009) 
and close friends (p=0.01).
The authors concluded that perceived risk is associated 
with both past sharing and preparedness to share in the 
future, particularly with groups of closer social proximity. 
Cognitive interventions which succeed in elevating perceived 
risk could reduce actual sharing with other IDU of close 
social proximity.
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Alcohol problems are more prevalent among older adults  ■
and may co-exist with problem drug use. Drug services 
may need to review their care systems to ensure that 
alcohol-related problems are recognised.
Many social, psychological and health problems may  ■
affect older adults and put them at increased risk of 
substance use. Such problems require specifi c attention if 
interventions for this group are to be fully effective.
Improved assessment of substance use disorders among  ■
older adults may require age-specifi c measures of 
use and dependence. Although the identifi cation of 
substance use disorders may be diffi cult, primary care 
and other healthcare services are well placed to screen 
for substance use problems.
Appropriate and effective treatment should be tailored  ■
to the specifi c needs of older drug users. This may 
require modifying existing forms of treatment, or 
developing new ones. In particular, treatment should be 
more attentive to co-morbid health conditions faced by 
older adults.
Drugs in focus (continued)
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The prevalence of self-reported deliberate self harm in 
Irish adolescents
Morey C, Corcoran P, Arensman E and Perry IJ 
BMC Public Health 2008; 8: 79 
This article is available at www.biomedcentral.com/1471-24 
58/8/79
Deliberate self harm (DSH) is a major public health problem, 
in particular among young people. Although several studies 
have addressed the prevalence of DSH among young people 
in the community, little is known about the extent to which 
DSH comes to the attention of medical services, the self 
harm methods used and the underlying motives. The aim 
of this study was to determine the prevalence of DSH in 
adolescents and the methods, motives and help seeking 
behaviour associated with this behaviour. 
A cross-sectional survey using an anonymous self-report 
questionnaire was administered in 39 schools in the 
Southern area of the Health Service Executive, Ireland. Of 
the 4,583 adolescents aged 15-17 years who were invited 
to participate in the survey, 3,881 adolescents took part 
(response: 85%). A lifetime history of DSH was reported 
by 9.1% (n = 333) of the adolescents. DSH was more 
common among females (13.9%) than males (4.3%). 
Self cutting (66.0%) and overdose (35.2%) were the 
most common DSH methods. A minority of participants 
accessed medical services after engaging in DSH (15.3%). 
The authors conclude that DSH is a signifi cant problem 
in Irish adolescents and the vast majority do not come to 
the attention of health services. Innovative solutions for 
prevention and intervention are required to tackle DSH 
in adolescents.
Alcohol, cognitive impairment and the hard to discharge 
acute hospital inpatients 
Popoola A, Keating A and Cassidy E 
Irish Journal of Medical Science 2008; 177(2): 141–145
The aim of this research was to examine the role of alcohol 
and alcohol-related cognitive impairment in the clinical 
presentation of adult in-patients less than 65 years who 
are ‘hard to discharge’ in a general hospital. The authors 
conducted a retrospective medical fi le review of in-patients 
in CUH referred to the discharge coordinator between 
March and September 2006. 
Of 46 patients identifi ed, the case notes of 44 (25 male; age 
was 52.2 ± 7.7 years) were reviewed. The average length 
of stay in the hospital was 84.0 ± 72.3 days and mean lost 
bed days was 15.9 ± 36.6 days. The number of patients 
documented to have an overt alcohol problem was 15 
(34.1%). Patients with alcohol problems were more likely to 
have cognitive impairment than those without an alcohol 
problem [12 (80%) and 9 (31%) P = 0.004]. Patients with 
alcohol problems had a shorter length of stay (81.5 vs. 85.3 
days; t = 0.161, df = 42, P = 0.87), fewer lost bed days (8.2 
vs. 19.2 days; Mann–Whitney U = 179, P = 0.34) and no 
mortality (0 vs. 6) compared with hard to discharge patients 
without alcohol problems. 
The authors concluded that alcohol problems and alcohol-
related cognitive impairment are hugely over-represented 
in acute hospital in-patients who are hard to discharge. 
Despite these problems, this group appears to have reduced 
morbidity, less lost bed days and a better outcome than 
other categories of hard to discharge patients. There is a 
need to resource acute hospitals to address alcohol-related 
morbidity in general and Wernicke–Korsakoff Syndrome in 
particular. 
(Compiled by Louise Farragher)
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Upcoming events
(Compiled by Louise Farragher – lfarragher@hrb.ie)
September
8–10 September 2008 
World Forum Against Drugs 
Venue: City Conference Centre, Folkets Hus, Stockholm 
Organised by / Contact: World Forum Against Drugs 
Tel: +46 8 644 21 74 
Email: @ info@wfad08.org 
www.wfad08.org 
Information: The fi rst World Forum Against Drugs will 
take place in Stockholm, Sweden. The main theme for the 
conference is ‘One hundred years of drug prevention’. 
Speakers at the conference will be some of the most 
prominent people in the world in the fi eld of anti-drug work, 
people working practically with local projects and people 
with personal experiences of great interest. World Forum 
welcomes individuals and organisations campaigning to 
achieve a society free from the abuse of illicit drugs.
15–16 September 
1st Global Conference on Methamphetamine: Science, 
Strategy and Response 
Venue: Prague City Hall, Czech Republic 
Organised by / Contact: Weave Consulting 
www.globalmethconference.com 
Information: The primary objective of this conference is 
to provide an arena for the world’s preeminent scientists, 
leaders, and professionals working on issues related to 
methamphetamine to gather to discuss the intersection 
between methamphetamine use, public health, law 
enforcement, and civil society.
The conference has been organized in response to an 
emerging consensus among experts that methamphetamine 
use is a complex problem that presents a signifi cant 
challenge to existing philosophies and strategies. While local 
and national communities are under siege by a perceived 
methamphetamine epidemic rush to pursue solutions, many 
facets of the problem remain to be discovered, examined, 
debated, illuminated and verifi ed.
drugnet 
IRELAND
The Alcohol and Drug Research Unit (ADRU) of the Health Research Board is a multi-
disciplinary team of researchers and information specialists who provide objective, reliable 
and comparable information on the drug and alcohol situation, its consequences and 
responses in Ireland. 
The ADRU maintains two national drug-related surveillance systems and is the national 
focal point for the European Monitoring Centre for Drugs and Drug Addiction. The unit also 
manages the National Documentation Centre on Drug Use.
The ADRU disseminates research fi ndings, information and news through its quarterly 
newsletter, Drugnet Ireland, and other publications. Through its activities, the ADRU aims to 
inform policy and practice in relation to drug and alcohol use.
Drugnet Ireland is published by:
Alcohol and Drug Research Unit
Health Research Board
Knockmaun House
42–47 Lower Mount Street
Dublin 2
Tel: 01 2345 127
Email: adru@hrb.ie
Managing editor: Brian Galvin
Editor: Joan Moore
October
27–28 October 2008 
2008 National Conference on Injecting Drug 
Use
Venue: London West Novotel, Hammersmith 
Organised by / Contact: Exchangesupplies 
www.exchangesupplies.org
Information: A packed and varied programme 
with over 30 parallel sessions, meetings, 
poster presentations and fi lms to inform 
practice, disseminate research, explore policy 
and develop skills. Conference highlights will 
include:
The launch of the 2008 ‘shooting up’ • 
report
Draft NICE guidance – what it said, how • 
you responded
Promoting the transition from injecting • 
to smoking
Injecting-related bacterial infections• 
TB and blood-borne viruses• 
Speedball injecting• 
Teaching people to access veins – • 
practical issues
The injecting of human growth hormone • 
(HGH) explained
November
13–14 November 2008 
The Society for the Study of Addiction 2008 
Symposium. Addiction Across the Life Span: 
Tracking Processes of Recovery
Venue: Park Inn, York, UK 
Organised by / Contact: Society for the Study 
of Addiction 
Tel: +44 (0)113 295 2787 
Email: graham.hunt@leedspft.nhs.uk 
www.addiction-ssa.org 
Information: This year’s event focuses on 
‘Addiction Across the Life Span, Tracking 
Processes of Recovery’. Please send abstracts 
for consideration as delegates’ oral/poster 
presentations to: Graham Hunt, Executive 
Offi ce, SSA, 19 Springfi eld Mount, Leeds, LS2 
9NG. Email: membership@addiction-ssa.org  
Any addiction-related subject will be considered, 
and all poster papers are eligible for the £500 
poster prize, to be awarded by an independent 
panel. More details will follow shortly.
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